UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from_______________ to _______________

 

Commission file number 1-10435

 

STURM, RUGER & COMPANY, INC.
(Exact name of registrant as specified in its charter)

 

Delaware   06-0633559
(State or other jurisdiction of   (I.R.S. employer
incorporation or organization)   identification no.)
     
One Lacey Place, Southport, Connecticut   06890
(Address of principal executive offices)   (Zip code)

(203) 259-7843

(Registrant's telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $1 par value RGR New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such requirements for the past 90 days. Yes ☒        No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒         No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☒        Accelerated filer ☐        Non-accelerated filer ☐         Smaller reporting company        Emerging growth company

 

☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐        No

 

The number of shares outstanding of the issuer's common stock as of October 20, 2023: 17,722,682

 

 

 

INDEX

 

STURM, RUGER & COMPANY, INC.

 

 

PART I. FINANCIAL INFORMATION  
     
Item 1. Financial Statements (Unaudited)  
     
  Condensed consolidated balance sheets – September 30, 2023 and December 31, 2022 3
     
  Condensed consolidated statements of income and comprehensive income – Three and nine months ended September 30, 2023 and October 1, 2022 5
     
  Condensed consolidated statement of stockholders’ equity – Nine months ended September 30, 2023 6
     
  Condensed consolidated statements of cash flows Nine months ended September 30, 2023 and October 1, 2022 7
     
  Notes to condensed consolidated financial statements – September 30, 2023 8
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 19
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 28
     
Item 4. Controls and Procedures 28
     
     
PART II. OTHER INFORMATION  
     
Item 1. Legal Proceedings 29
     
Item 1A. Risk Factors 29
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 29
     
Item 3. Defaults Upon Senior Securities 29
     
Item 4. Mine Safety Disclosures 29
     
Item 5. Other Information 30
     
Item 6. Exhibits 31
     
SIGNATURES 32

 

 

2 

 

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

 

STURM, RUGER & COMPANY, INC.

 

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Dollars in thousands)

 

   September 30, 2023   December 31, 2022 
       (Note) 
         
Assets          
           
Current Assets          
Cash  $13,559   $65,173 
Short-term investments   106,451    159,132 
Trade receivables, net   59,899    65,449 
           
Gross inventories (Note 4)   150,021    129,294 
Less LIFO reserve   (64,969)   (59,489)
Less excess and obsolescence reserve   (5,781)   (4,812)
Net inventories   79,271    64,993 
           
Prepaid expenses and other current assets   14,780    7,091 
Total Current Assets   273,960    361,838 
           
Property, plant and equipment   458,332    447,126 
Less allowances for depreciation   (388,531)   (370,273)
Net property, plant and equipment   69,801    76,853 
           
Deferred income taxes   10,167    6,109 
Other assets   46,422    39,963 
Total Assets  $400,350   $484,763 

 

Note:

 

The Condensed Consolidated Balance Sheet at December 31, 2022 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

 

See notes to condensed consolidated financial statements.

3 

 

 

STURM, RUGER & COMPANY, INC.

 

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Continued)

(Dollars in thousands, except per share data)

 

   September 30, 2023   December 31, 2022 
       (Note) 
         
Liabilities and Stockholders’ Equity          
           
Current Liabilities          
Trade accounts payable and accrued expenses  $29,736   $35,658 
Dividends payable   
    88,343 
Contract liabilities with customers (Note 3)   1,436    1,031 
Product liability   406    235 
Employee compensation and benefits   23,142    30,160 
Workers’ compensation   6,467    6,469 
Income taxes payable   
    1,171 
Total Current Liabilities   61,187    163,067 
           
Employee compensation   1,484    1,846 
Product liability accrual   46    73 
Lease liability (Note 5)   2,328    3,039 
           
Contingent liabilities (Note 13)   
    
 
           
           
Stockholders’ Equity          
Common Stock, non-voting, par value $1:
   
 
    
 
 
Authorized shares 50,000; none issued        
Common Stock, par value $1:          
Authorized shares – 40,000,000          
2023 – 24,437,020 issued,          
17,722,682 outstanding          
2022 – 24,378,568 issued,          
17,664,230 outstanding   24,437    24,378 
Additional paid-in capital   45,828    45,075 
Retained earnings   410,852    393,097 
Less: Treasury stock – at cost          
2023 – 6,714,338 shares          
2022 – 6,714,338 shares   (145,812)   (145,812)
Total Stockholders’ Equity   335,305    316,738 
Total Liabilities and Stockholders’ Equity  $400,350   $484,763 

 

Note:

 

The Condensed Consolidated Balance Sheet at December 31, 2022 has been derived from the audited consolidated financial statements at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

 

See notes to condensed consolidated financial statements.

 

4 

 

 

STURM, RUGER & COMPANY, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (UNAUDITED)

(Dollars in thousands, except per share data)

 

   Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
                 
Net firearms sales  $120,368   $138,771   $411,114   $444,615 
Net castings sales   525    619    2,036    2,003 
Total net sales   120,893    139,390    413,150    446,618 
                     
Cost of products sold   96,165    100,521    311,788    306,087 
                     
Gross profit   24,728    38,869    101,362    140,531 
                     
Operating expenses:                    
Selling   8,669    8,763    27,702    25,828 
General and administrative   9,733    10,247    31,898    30,927 
Total operating expenses   18,402    19,010    59,600    56,755 
                     
Operating income   6,326    19,859    41,762    83,776 
                     
Other income:                    
Interest income   1,454    730    4,147    951 
Interest expense   (122)   (88)   (177)   (205)
Other income, net   431    490    1,082    2,092 
Total other income, net   1,763    1,132    5,052    2,838 
                     
Income before income taxes   8,089    20,991    46,814    86,614 
                     
Income taxes   658    2,602    8,848    17,236 
                     
Net income and comprehensive income  $7,431   $18,389   $37,966   $69,378 
                     
Basic earnings per share  $0.42   $1.04   $2.14   $3.93 
                     
Diluted earnings per share  $0.42   $1.03   $2.13   $3.90 
                     
Weighted average number of common shares outstanding - Basic   17,722,682    17,668,435    17,705,280    17,643,473 
                     
Weighted average number of common shares outstanding - Diluted   17,889,089    17,825,797    17,828,710    17,770,120 
                     
Cash dividends per share  $0.36   $0.47   $6.10   $2.01 

 

 

See notes to condensed consolidated financial statements.

 

5 

 

STURM, RUGER & COMPANY, INC.

 

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (UNAUDITED)

(Dollars in thousands)

 

   Common
Stock
   Additional
Paid-in
Capital
   Retained
Earnings
   Treasury
Stock
   Total 
                     
Balance at December 31, 2022  $24,378   $45,075   $393,097   $(145,812)  $316,738 
                          
Net income and comprehensive income             37,966         37,966 
                          
Common stock issued – compensation plans   59    (59)             
 
                          
Vesting of RSUs        (2,156)             (2,156)
                          
Dividends paid             (19,462)        (19,462)
                          
Unpaid dividends accrued             (749)        (749)
                          
Recognition of stock-based compensation expense        2,968              2,968 
                          
Balance at September 30, 2023  $24,437   $45,828   $410,852   $(145,812)  $335,305 

 

 

See notes to condensed consolidated financial statements.

 

6 

 

 

STURM, RUGER & COMPANY, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Dollars in thousands)

 

   Nine Months Ended 
   September 30,
2023
   October 1,
2022
 
         
Operating Activities          
Net income  $37,966   $69,378 
Adjustments to reconcile net income to cash provided by operating activities:          
Depreciation and amortization   19,576    20,120 
Stock-based compensation   2,968    5,053 
(Gain) loss on sale of assets   (4)   15 
Deferred income taxes   (4,058)   (1,908)
Changes in operating assets and liabilities:          
Trade receivables   5,550    (4,326)
Inventories   (14,278)   (17,655)
Trade accounts payable and accrued expenses   (5,967)   (5,315)
Contract liability with customers   405    
 
Employee compensation and benefits   (8,129)   (11,774)
Product liability   144    (340)
Prepaid expenses, other assets and other liabilities   (15,704)   (2,985)
Income taxes payable   (1,171)   
 
Cash provided by operating activities   17,298    50,263 
           
Investing Activities          
Property, plant and equipment additions   (11,637)   (17,206)
Proceeds from sale of assets   5    41 
Purchases of short-term investments   (141,410)   (200,378)
Proceeds from maturities of short-term investments   194,091    235,041 
Cash provided by investing activities   41,049    17,498 
           
Financing Activities          
Remittance of taxes withheld from employees related to share-based compensation   (2,156)   (3,371)
Repurchase of common stock   
    (107)
Dividends paid   (107,805)   (35,474)
Cash used for financing activities   (109,961)   (38,952)
           
(Decrease) increase in cash and cash equivalents   (51,614)   28,809 
           
Cash and cash equivalents at beginning of period   65,173    21,044 
           
Cash and cash equivalents at end of period  $13,559   $49,853 

 

 

See notes to condensed consolidated financial statements.

 

7 

 

 

STURM, RUGER & COMPANY, INC.

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(Dollars in thousands, except per share)

 

 

NOTE 1 - BASIS OF PRESENTATION

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the results of the interim periods. Operating results for the three and nine months ended September 30, 2023 may not be indicative of the results to be expected for the full year ending December 31, 2023. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

 

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

 

Organization:

 

Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales are from firearms. Export sales accounted for approximately 7% of total sales for the nine month periods ended September 30, 2023 and October 1, 2022. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors, principally to the commercial sporting market.

 

The Company also manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and for sale to unaffiliated, third-party customers. Approximately 1% of sales are from the castings segment.

 

Principles of Consolidation:

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany accounts and transactions have been eliminated.

 

Revenue Recognition:

 

The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”). Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company’s products from the independent distributors. The fulfillment of these no charge products is the Company’s responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales.

 

8 

 

Fair Value of Financial Instruments:

 

The carrying amounts of financial instruments, including cash, short-term investments, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to the short-term maturity of these items.

 

The Company’s short-term investments consist of United States Treasury instruments, which mature within one year, and investments in a bank-managed money market fund that invests exclusively in United States Treasury obligations and is valued at the net asset value ("NAV") daily closing price, as reported by the fund, based on the amortized cost of the fund’s securities. The NAV is used as a practical expedient to estimate fair value. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV.

 

Use of Estimates:

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

 

 

NOTE 3 - REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

 

The impact of ASC 606 on revenue recognized during the three and nine months ended September 30, 2023 and October 1, 2022 is as follows:

 

   Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
                 
Contract liabilities with customers at beginning of period  $100   $
   $1,031   $
 
                     
Revenue deferred   1,468    
    1,680    
 
                     
Revenue recognized   (132)   
    (1,275)   
 
                     
Contract liabilities with customers at end of period  $1,436   $
   $1,436   $
 

 

9 

 

As more fully described in the Revenue Recognition section of Note 2, the deferral of revenue and subsequent recognition thereof relates to certain of the Company’s sales promotion programs that include the future shipment of free products. The Company expects the remaining deferred revenue from this contract liability with customers to be recognized in the fourth quarter of 2023.

 

Practical Expedients and Exemptions

 

The Company has elected to account for shipping and handling activities that occur after control of the related product transfers to the customer as fulfillment activities that are recognized upon shipment of the goods.

 

 

NOTE 4 - INVENTORIES

 

Inventories are valued using the last-in, first-out (LIFO) method. An actual valuation of inventory under the LIFO method can be made only at the end of each year based on the inventory levels and costs existing at that time. Accordingly, interim LIFO calculations must necessarily be based on management's estimates of expected year-end inventory levels and costs. Because these are subject to many factors beyond management's control, interim results are subject to the final year-end LIFO inventory valuation.

 

Inventories consist of the following:

 

   September 30, 2023   December 31, 2022 
Inventory at FIFO          
Finished products  $31,907   $23,573 
Materials and work in process   118,114    105,721 
Gross inventories   150,021    129,294 
Less: LIFO reserve   (64,969)   (59,489)
Less: excess and obsolescence reserve   (5,781)   (4,812)
Net inventories  $79,271   $64,993 

 

 

NOTE 5 - LEASED ASSETS

 

The Company leases certain of its real estate and equipment. The Company has evaluated all its leases and determined that all are operating leases under the definitions of the guidance of ASU 2016-02, Leases (Topic 842). The Company’s lease agreements generally do not require material variable lease payments, residual value guarantees or restrictive covenants.

 

10 

 

Under the provisions of ASU 2016-02, the Company records right-of-use assets equal to the present value of the contractual liability for future lease payments. The table below presents the right-of- use assets and related lease liabilities recognized on the Condensed Consolidated Balance Sheet as of September 30, 2023:

 

   Balance Sheet Line Item  September 30, 2023 
Right-of-use assets  Other assets  $2,926 
         
Operating lease liabilities        
         
Current portion  Trade accounts payable and accrued expenses  $598 
         
Noncurrent portion  Lease liabilities   2,328 
         
Total operating lease liabilities     $2,926 

 

The depreciable lives of right-of-use assets are limited by the lease term and are amortized on a straight line basis over the life of the lease.

 

The Company’s leases generally do not provide an implicit interest rate, and therefore the Company calculates an incremental borrowing rate to determine the present value of its operating lease liabilities. The following table reconciles the undiscounted future minimum lease payments to the total operating lease liabilities recognized on the Condensed Consolidated Balance Sheet as of September 30, 2023:

 

Remainder of 2023  $200 
2024   808 
2025   702 
2026   705 
2027   229 
Thereafter   1,120 
Total undiscounted future minimum lease payments   3,764 
Less: Difference between undiscounted lease payments & the present value of future lease payments   (838)
Total operating lease liabilities  $2,926 

 

Certain of the Company’s lease agreements contain renewal options at the Company’s discretion. The Company does not recognize right-of-use assets or lease liabilities for leases of one year or less or for renewal periods unless it is reasonably certain that the Company will exercise the renewal option at the inception of the lease or when a triggering event occurs. The Company’s weighted average remaining lease term for operating leases as of September 30, 2023 is 8.1 years.

 

 

NOTE 6 - LINE OF CREDIT

 

On January 7, 2022, the Company entered into a $40 million unsecured revolving line of credit agreement with a bank that expires January 7, 2025. Borrowings under this new facility bear interest at either 1) the Bloomberg short-Term Bank Yield Index – 1 month plus 150 basis points, or 2) a fluctuating rate per annum equal to the greater of (i) the Bank’s prime rate or (ii) the federal funds rate plus 50 basis points. The Company is also charged one-quarter of a percent (0.25%) per year on the unused portion. At September 30, 2023, the Company was in compliance with the terms and covenants of the credit facility and the line of credit was unused.

 

 

11 

 

NOTE 7 - EMPLOYEE BENEFIT PLANS

 

The Company sponsors a 401(k) plan that covers substantially all employees. The Company matches a certain portion of employee contributions using the safe harbor guidelines contained in the Internal Revenue Code. Expenses related to these matching contributions totaled $1.0 million and $3.7 million for the three and nine months ended September 30, 2023, respectively, and $0.9 million and $3.1 million for the three and nine months ended October 1, 2022, respectively. The Company plans to contribute approximately $1.0 million to the plan in matching employee contributions during the remainder of 2023.

 

In addition, the Company provided supplemental discretionary contributions to the 401(k) plan totaling $1.6 million and $5.3 million for the three and nine months ended September 30, 2023, respectively, and $1.5 million and $5.4 million for the three and nine months ended October 1, 2022, respectively. The Company plans to contribute approximately $1.6 million in supplemental contributions to the plan during the remainder of 2023.

 

 

NOTE 8 - INCOME TAXES

 

The Company's 2023 and 2022 effective tax rates differ from the statutory federal tax rate due principally to the availability of research and development tax credits, state income taxes, and the nondeductibility of certain executive compensation. The Company’s effective income tax rate was 8.1% and 18.9% for the three and nine months ended September 30, 2023, respectively. The Company’s effective income tax rate was 12.4% and 19.9% for the three and nine months October 1, 2022, respectively. The lower effective income tax rates for the three and nine months ended September 30, 2023 resulted from the recognition of higher than anticipated tax credits that were noted when the Company filed its 2022 Federal and state income tax returns.

 

Income tax payments for the three and nine months ended September 30, 2023 totaled $7.3 million and $23.8 million, respectively. Income tax payments for the three and nine months ended October 1, 2022 totaled $6.0 million and $26.6 million, respectively.

 

The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal and state income tax examinations by tax authorities for years before 2018.

 

The Company does not believe it has included any “uncertain tax positions” in its federal income tax return or any of the state income tax returns it is currently filing. The Company has made an evaluation of the potential impact of additional state taxes being assessed by jurisdictions in which the Company does not currently consider itself liable. The Company does not anticipate that such additional taxes, if any, would result in a material change to its financial position.

 

 

12 

 

NOTE 9 - EARNINGS PER SHARE

 

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the periods indicated:

 

   Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
Numerator:                
Net income  $7,431   $18,389   $37,966   $69,378 
                     
Denominator:                    
Weighted average number of common shares outstanding – Basic   17,722,682    17,668,435    17,705,280    17,643,473 
                     
Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans   166,407    157,362    123,430    126,647 
                     
Weighted average number of common shares outstanding – Diluted   17,889,089    17,825,797    17,828,710    17,770,120 

 

The dilutive effect of outstanding options and restricted stock units is calculated using the treasury stock method. There were no stock options that were anti-dilutive and therefore not included in the diluted earnings per share calculation.

 

 

NOTE 10 - COMPENSATION PLANS

 

In May 2017, the Company’s shareholders approved the 2017 Stock Incentive Plan (the “2017 SIP”) under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors. The Company reserved 750,000 shares for issuance under the 2017 SIP.

 

In June 2023, the Company’s shareholders approved the 2023 Stock Incentive Plan (the “2023 SIP”) under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors. The Company reserved 1,000,000 shares for issuance under the 2023 SIP, of which 869,000 shares remain available for future grants as of September 30, 2023. Any shares remaining from the 2017 SIP will be available for future grants under the terms of the 2023 SIP. As of September 30, 2023, 121,034 shares remained unawarded from the 2017 SIP. Since the shareholder approval of the 2023 SIP, no additional awards have been or will be granted under the 2017 SIP. Previously granted and outstanding awards under the 2017 SIP will remain subject to the terms of the 2017 SIP.

 

13 

 

Restricted Stock Units

 

The Company grants performance-based and retention-based restricted stock units to senior employees. The vesting of the performance-based awards is dependent on the achievement of corporate objectives established by the Compensation Committee of the Board of Directors and a three-year vesting period. The retention-based awards are subject only to a three-year vesting period. There were 113,862 restricted stock units issued during the nine months ended September 30, 2023. Total compensation costs related to these restricted stock units are $6.1 million.

 

Compensation costs related to all outstanding restricted stock units recognized in the statements of income aggregated $1.6 million and $5.0 million for the three and nine months ended September 30, 2023, respectively, and $1.7 million and $5.1 million for the three and nine months ended October 1, 2022, respectively.

 

 

NOTE 11 - OPERATING SEGMENT INFORMATION

 

The Company has two reportable segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a select number of independent wholesale distributors primarily located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts.

 

Selected operating segment financial information follows:

 

(in thousands)  Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
Net Sales                    
Firearms  $120,368   $138,771   $411,114   $444,615 
Castings                    
Unaffiliated   525    619    2,036    2,003 
Intersegment   7,947    4,453    25,307    13,781 
    8,472    5,072    27,343    15,784 
Eliminations   (7,947)   (4,453)   (25,307)   (13,781)
   $120,893   $139,390   $413,150   $446,618 
                     
Income (Loss) Before Income Taxes                    
Firearms  $6,108   $21,339   $43,637   $88,130 
Castings   420    (1,029)   (1,178)   (2,754)
Corporate   1,561    681    4,355    1,238 
   $8,089   $20,991   $46,814   $86,614 
                     
Depreciation                    
Firearms  $5,676   $5,815   $17,027   $17,430 
Castings   553    574    1,661    1,736 
   $6,229   $6,389   $18,688   $19,166 
                     
Capital Expenditures                    
Firearms  $6,674   $2,324   $11,456   $15,971 
Castings   90    552    181    1,235 
   $6,764   $2,876   $11,637   $17,206 

 

14 

 

   September 30,
2023
   December 31,
2022
 
Identifiable Assets          
Firearms  $230,340   $223,301 
Castings   10,137    11,910 
Corporate   159,873    249,552 
   $400,350   $484,763 
Goodwill        
Firearms  $3,055   $3,055 
Castings   209    209 
   $3,264   $3,264 

 

 

NOTE 12 - RELATED PARTY TRANSACTIONS

 

The Company contracts with the National Rifle Association (“NRA”) for some of its promotional and advertising activities. Payments made to the NRA in the three and nine months ended September 30, 2023 totaled $0.1 million and $0.4 million, respectively. Payments made to the NRA in the three and nine months ended October 1, 2022 totaled $0.2 million and $0.4 million, respectively. One of the Company’s Directors also serves as a Director on the Board of the NRA.

 

The Company is a member of the National Shooting Sports Foundation (“NSSF”), the firearm industry trade association.  Payments made to the NSSF in the three and nine month periods ended September 30, 2023 totaled $0.1 million and $0.3 million, respectively.   Payments made to the NSSF in the three and nine months ended October 1, 2022 totaled $0.1 million and $0.2 million, respectively. One of the Company’s Directors also serves on the Board of the NSSF.

 

 

NOTE 13 - CONTINGENT LIABILITIES

 

As of September 30, 2023, the Company was a defendant in eight (8) lawsuits and is aware of certain other such claims. The lawsuits fall into three categories: municipal litigation, negligence, and unfair trade practices. Each is discussed in turn below.

 

Municipal Litigation

 

Municipal litigation generally includes those cases brought by cities or other governmental entities against firearms manufacturers, distributors and retailers seeking to recover damages allegedly arising out of the misuse of firearms by third parties. There are four lawsuits of this type: the City of Gary, filed in Indiana State Court in 1999; Estados Unidos Mexicanos v. Smith & Wesson, et al., filed in the U.S. District Court for the District of Massachusetts in August 2021; The City of Buffalo, filed in the Supreme Court of the State of New York for Erie County on December 20, 2022; and The City of Rochester, filed in the Supreme Court for the State of New York for Monroe County on December 21, 2022, each of which is described in more detail below.

 

The City of Gary Complaint seeks damages, among other things, for the costs of medical care, police and emergency services, public health services, and other services as well as punitive damages. In addition, nuisance abatement and/or injunctive relief is sought to change the design, manufacture, marketing and distribution practices of the various defendants. The suit alleges, among other claims, negligence in the design of products, public nuisance, negligent distribution and marketing, negligence per se and deceptive advertising. The case does not allege a specific injury to a specific individual as a result of the misuse or use of any of the Company's products. After a long procedural history, during the quarter ended April 3, 2021, the City initiated discovery and the manufacturer defendants reciprocated. Discovery is ongoing.

 

15 

 

Estados Unidos Mexicanos v. Smith & Wesson Brands, Inc., et al. was filed by the Country of Mexico and names seven defendants, mostly U.S.-based firearms manufacturers, including the Company. The Complaint advances a variety of legal theories including negligence, public nuisance, unjust enrichment, restitution, and others. Plaintiff essentially alleges that Defendants design, manufacture, distribute, market and sell firearms in a way that they know results in the illegal trafficking of firearms into Mexico, where they are used by Mexican drug cartels for criminal activities. Plaintiff seeks injunctive relief and monetary damages. On November 22, 2021, defendants filed a joint Rule 12(b)(6) motion to dismiss the Mexican Government’s complaint. On September 30, 2022, the court entered an order granting defendants’ motion. On October 26, 2022, plaintiff filed a Notice of Appeal and the matter is being briefed before the First Circuit Court of Appeals. Oral argument was held on July 24, 2023.

 

On December 20, 2022, the City of Buffalo, New York filed a lawsuit captioned The City of Buffalo v. Smith & Wesson Brands, Inc., et al. in the New York State Supreme Court for Erie County, New York. The suit names a number of firearm manufacturers, distributors, and retailers as defendants, including the Company, and purports to state causes of action for violations of Sections 898, 349 and 350 of the New York General Business Law, as well as common law public nuisance. Generally, plaintiff alleges that the criminal misuse of firearms in the City of Buffalo is the result of the manufacturing, sales, marketing, and distribution practices of the defendants. Defendants timely removed the matter to the U.S. District Court for the Western District of New York.

 

On December 21, 2022, the City of Rochester, New York filed a lawsuit captioned The City of Rochester v. Smith & Wesson Brands, Inc., et al. in the New York State Supreme Court for Monroe County, New York. The allegations essentially mirror those in The City of Buffalo, discussed in the preceding paragraph. Defendants timely removed the matter to the U.S. District Court for the Western District of New York.

 

Defendants moved to consolidate the The City of Buffalo and The City of Rochester cases for pretrial purposes only. Defendants also moved to stay the cases pending a decision by the Second Circuit Court of Appeals in National Shooting Sports Foundation, Inc. et al. v. James, which challenges the constitutionality of the recently enacted N.Y. Gen. Bus. Law §§ 898-a–e. On June 8, 2023, the court granted defendants’ motions and the cases were consolidated for pretrial purposes and stayed.

 

Negligence

 

Rossiter v. Sturm, Ruger, et al. is a lawsuit arising out of a slip and fall accident by a contract security officer in December 2019. The Complaint was filed in the Superior Court for Sullivan County, New Hampshire on December 13, 2022 and names Pine Hill Construction, a snow removal contractor, as a co-defendant. The Company has tendered the defense of this matter to its insurance carrier and is assisting as required.

 

16 

 

The Company was named in two purported class action lawsuits arising out of a data breach at Freestyle Solutions, Inc., the vendor who hosted the Company’s ShopRuger.com website at the time of the breach. Jones v. Sturm, Ruger & Co., was filed in the U.S. District Court for Connecticut on October 4, 2022 and Copeland v. Sturm, Ruger & Company, et al. was filed in the U.S. District Court for New Jersey on October 27, 2022. Copeland also named Freestyle Solutions, Inc. as a defendant. By agreement of the parties, Copeland was dismissed, without prejudice, and consolidated with Jones in the pending Connecticut case. On January 20, 2023, five plaintiffs filed an Amended Complaint naming the Company and Freestyle Software, Inc. as defendants. The Complaint alleges causes of action for negligence, breach of implied warranties, and unjust enrichment. The Company filed a Motion to Dismiss on a variety of grounds. The matter has been briefed fully, and a decision is pending.

 

Unfair Trade Practices

 

Estate of Suzanne Fountain v. Sturm, Ruger & Co., Inc., was filed in the Connecticut Superior Court in Stamford and arises out of the criminal shootings at the King Soopers supermarket in Boulder, Colorado on March 22, 2021. On that date, plaintiff’s decedent, Suzanne Fountain, was murdered by 21-year-old Ahmad Al Aliwi Al-Issa. The Complaint alleges that the Company’s advertising and marketing of the Ruger AR-556 pistol violate the Connecticut Unfair Trade Practices Act and were a substantial factor in bringing about the wrongful death of Suzanne Fountain.

 

Estate of Neven Stanisic et al. v. Sturm, Ruger & Co., Inc., was filed in the Connecticut Superior Court in Stamford on behalf of five plaintiffs. Like Estate of Suzanne Fountain, the claims arise from the criminal shootings at the King Soopers supermarket in Boulder, Colorado on March 22, 2021. Plaintiffs’ decedents were murdered by Ahmad Al Aliwi Al-Issa and plaintiffs allege that the Company’s advertising and marketing of the Ruger AR-556 pistol violate the Connecticut Unfair Trade Practices Act and were a substantial factor in causing the wrongful death of plaintiffs’ decedents.

 

The Fountain and Stanisic cases have been consolidated for discovery purposes only and transferred by the court to the Complex Litigation Docket. Plaintiffs sought leave to file an amended complaint, essentially abandoning their negligent marketing allegations and advancing a new theory predicated upon alleged violations of the Gun Control Act and National Firearms Act. Over the Company’s objections, plaintiffs were permitted to file the amended complaint. The matter was timely removed to the U.S. District Court for the District of Connecticut based upon federal question jurisdiction.

 

Summary of Claimed Damages and Explanation of Product Liability Accruals

 

Punitive damages, as well as compensatory damages, are demanded in certain of the lawsuits and claims. In many instances, the plaintiff does not seek a specified amount of money, though aggregate amounts ultimately sought may exceed product liability accruals and applicable insurance coverage. For product liability claims made after July 10, 2000, coverage is provided on an annual basis for losses exceeding $5 million per claim, or an aggregate maximum loss of $10 million annually, except for certain new claims which might be brought by governments or municipalities after July 10, 2000, which are excluded from coverage.

 

The Company management monitors the status of known claims and the product liability accrual, which includes amounts for asserted and unasserted claims. While it is not possible to forecast the outcome of litigation or the timing of costs, in the opinion of management, after consultation with special and corporate counsel, it is not probable and is unlikely that litigation, including punitive damage claims, will have a material adverse effect on the financial position of the Company, but may have a material impact on the Company's financial results for a particular period.

 

Product liability claim payments are made when appropriate if, as, and when claimants and the Company reach agreement upon an amount to finally resolve all claims. Legal costs are paid as lawsuits and claims develop, the timing of which may vary greatly from case to case. A time schedule cannot be determined in advance with any reliability concerning when payments will be made in any given case.

 

17 

 

Provision is made for product liability claims based upon many factors related to the severity of the alleged injury and potential liability exposure, based upon prior claim experience. Because the Company's experience in defending these lawsuits and claims is that unfavorable outcomes are typically not probable or estimable, only in rare cases is an accrual established for such costs.

 

In most cases, an accrual is established only for estimated legal defense costs. Product liability accruals are periodically reviewed to reflect then-current estimates of possible liabilities and expenses incurred to date and reasonably anticipated in the future. Threatened product liability claims are reflected in the Company's product liability accrual on the same basis as actual claims; i.e., an accrual is made for reasonably anticipated possible liability and claims handling expenses on an ongoing basis.

 

A range of reasonably possible losses relating to unfavorable outcomes cannot be made. However, in product liability cases in which a dollar amount of damages is claimed, the amount of damages claimed, which totaled $1.1 million at December 31, 2021, is set forth as an indication of possible maximum liability the Company might be required to incur in these cases (regardless of the likelihood or reasonable probability of any or all of this amount being awarded to claimants) as a result of adverse judgments that are sustained on appeal. At December 31, 2022, the total amount claimed specifically in these cases was de minimis.

 

 

NOTE 14 - SUBSEQUENT EVENTS

 

On October 27, 2023, the Board of Directors authorized a dividend of 17¢ per share, for shareholders of record as of November 15, 2023, payable on November 29, 2023.

 

The Company has evaluated events and transactions occurring subsequent to September 30, 2023 and determined that there were no other unreported events or transactions that would have a material impact on the Company’s results of operations or financial position.

18 

 

 

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Company Overview

 

Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales are from firearms. Export sales accounted for approximately 7% of total sales for the nine month periods ended September 30, 2023 and October 1, 2022. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors, principally to the commercial sporting market.

 

The Company also manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and for sale to unaffiliated, third-party customers. Less than 1% of sales are from the castings segment.

 

Orders for many models of firearms from the independent distributors tend to be stronger in the first quarter of the year and weaker in the third quarter of the year. This is due in part to the timing of the distributor show season, which occurs during the first quarter.

 

Results of Operations

 

Demand

 

The estimated unit sell-through of the Company’s products from the independent distributors to retailers decreased 8% in the first nine months of 2023 compared to the prior year period. For the same period, NICS background checks (as adjusted by the National Shooting Sports Foundation (“NSSF”)) decreased 7%. Estimated sell-through from the independent distributors to retailers and total adjusted NICS background checks for the trailing seven quarters follow:

 

   2023  2022
   Q3  Q2  Q1  Q4  Q3  Q2  Q1
                      
Estimated Units Sold from Distributors to Retailers (1)   307,400    323,000    391,500    397,800    343,500    354,300    411,200 
                                    
Total adjusted NICS Background Checks (thousands) (2)   3,284    3,654    4,168    4,531    3,764    3,917    4,213 

 

(1)The estimates for each period were calculated by taking the beginning inventory at the distributors, plus shipments from the Company to distributors during the period, less the ending inventory at distributors. These estimates are only a proxy for actual market demand as they:

 

Rely on data provided by independent distributors that are not verified by the Company,
Do not consider potential timing issues within the distribution channel, including goods-in-transit, and
  Do not consider fluctuations in inventory at retail.

 

19 

 

(2)NICS background checks are performed when the ownership of most firearms, either new or used, is transferred by a Federal Firearms Licensee. NICS background checks are also performed for permit applications, permit renewals, and other administrative reasons.  

 

The adjusted NICS data presented above was derived by the NSSF by subtracting out NICS checks that are not directly related to the sale of a firearm, including checks used for concealed carry (“CCW”) permit application checks, as well as checks on active CCW permit databases. The adjusted NICS checks represent less than half of the total NICS checks.

 

Adjusted NICS data can be impacted by changes in state laws and regulations and any directives and interpretations issued by governmental agencies.

 

Orders Received and Ending Backlog

 

The Company uses the estimated unit sell-through of its products from the independent distributors to retailers, along with inventory levels at the independent distributors and at the Company, as the key metrics for planning production levels. The Company generally does not use the orders received or ending backlog for planning production levels.

 

The units ordered, value of orders received, average sales price of units ordered, and ending backlog for the trailing seven quarters are as follows (dollars in millions, except average sales price):

 

(All amounts shown are net of Federal Excise Tax of 10% for handguns and 11% for long guns.)

 

   2023  2022
   Q3  Q2  Q1  Q4  Q3  Q2  Q1
                      
Units Ordered   176,300    258,100    408,000    156,000    295,600    250,600    381,600 
                                    
Orders Received  $58.8   $102.1   $156.2   $81.0   $124.3   $98.9   $147.0 
                                    
Average Sales Price of Units Ordered  $334   $396   $383   $519   $421   $395   $385 
                                    
Ending Backlog  $234.8   $293.7   $327.3   $314.4   $377.6   $389.6   $420.5 
                                    
Average Sales Price of Ending Unit Backlog  $510   $496   $488   $486   $427   $405   $384 

 

 

Production

 

The Company reviews the estimated sell-through from the independent distributors to retailers, as well as inventory levels at the independent distributors and at the Company, semi-monthly to plan production levels. Consequently, the Company’s overall production in the first nine months of 2023 decreased by 18% from the first nine months of 2022.

 

20 

 

Summary Unit Data

 

Firearms unit data for the trailing seven quarters are as follows (dollar amounts shown are net of Federal Excise Tax of 10% for handguns and 11% for long guns):

 

   2023  2022
   Q3  Q2  Q1  Q4  Q3  Q2  Q1
                      
Units Ordered   176,300    258,100    408,000    156,000    295,600    250,600    381,600 
                                    
Units Produced   324,500    387,400    381,000    397,300    382,800    431,800    521,300 
                                    
Units Shipped   308,400    336,400    384,900    393,100    373,800    382,600    491,500 
                                    
Average Sales Price of Units Shipped  $390   $422   $387   $378   $371   $366   $338 
                                    
Ending Unit Backlog   460,000    592,100    670,400    647,300    884,400    962,600    1,094,600 
                                    
                                    

Inventories

During the third quarter of 2023, the Company’s finished goods inventory increased by 16,100 units and distributor inventories of the Company’s products increased by 1,000 units.

 

Inventory unit data for the trailing seven quarters follows:

 

   2023  2022
   Q3  Q2  Q1  Q4  Q3  Q2  Q1
                      
Company Inventory   176,100    160,000    108,900    112,800    108,600    99,700    50,400 
Distributor Inventory (1)   306,200    305,200    291,800    298,400    303,100    272,800    244,600 
                                    
Total Inventory (2)   482,300    465,200    400,700    411,200    411,700    372,500    295,000 
                                    
(1)Distributor ending inventory is provided by the Company’s independent distributors. These numbers do not include goods-in-transit inventory that has been shipped from the Company but not yet received by the distributors.

 

(2)This total does not include inventory at retailers. The Company does not have access to data on retailer inventories of the Company’s products.

 

21 

 

Net Sales, Cost of Products Sold, and Gross Profit

 

Net sales, cost of products sold, and gross profit data for the three months ended (dollars in millions):

 

   September 30,
2023
  October 1,
2022
  Change  % Change
Net firearms sales  $120.4   $138.8   $(18.4)   (13.3%)
                     
Net castings sales   0.5    0.6    (0.1)   (15.2%)
                     
Total net sales   120.9    139.4    (18.5)   (13.3%)
                     
Cost of products sold   96.2    100.5    (4.3)   (4.3%)
                     
Gross profit  $24.7   $38.9   $(14.2)   (36.4%)
                     
Gross margin   20.5%    27.9%    (7.4%)   (26.5%)

 

Sales of new products, including the LCP MAX pistol, Marlin lever-action rifles, LC Carbine, Small-Frame Autoloading Rifle, Super Wrangler revolver, and the Security-380 pistol, represented $27.2 million or 22.9% of firearm sales in the three months ended September 30, 2023. New product sales include only major new products that were introduced in the past two years.

 

The decreased gross profit for the three months ended September 30, 2023 is attributable to the decrease in sales, unfavorable deleveraging of fixed costs resulting from decreased production, increased promotional costs, inflationary cost increases in materials, commodities, services, wages, energy, fuel and transportation, and a product mix shift toward products with relatively lower margins that remain in relatively stronger demand.

 

The decrease in gross margin for the three months ended September 30, 2023 is attributable the aforementioned factors, partially offset by increased pricing.

 

Net sales, cost of products sold, and gross profit data for the nine months ended (dollars in millions):

 

   September 30,
2023
  October 1,
2022
  Change  % Change
Net firearms sales  $411.1   $444.6   $(33.5)   (7.5%)
                     
Net castings sales   2.1    2.0    0.1    1.6% 
                     
Total net sales   413.2    446.6    (33.4)   (7.5%)
                     
Cost of products sold   311.8    306.1    5.7    1.9% 
                     
Gross profit  $101.4   $140.5   $(39.1)   (27.9%)
                     
Gross margin   24.5%    31.5%    (7.0%)   (22.2%)

22 

 

 

The decrease in total consolidated net sales and net firearms sales for the three and nine months ended September 30, 2023 is attributable to decreased consumer demand for firearms, as evidenced by the adjusted NICS checks. Sales of new products, including the MAX-9 pistol (during the first quarter only), LCP MAX pistol, Marlin lever-action rifles, LC Carbine, Small-Frame Autoloading Rifle, Super Wrangler revolver, and the Security-380 pistol, represented $90.5 million or 22.7% of firearm sales in the first nine months of 2023. New product sales include only major new products that were introduced in the past two years.

 

The decreased gross profit for the nine months ended September 30, 2023 is attributable to the decrease in sales, inflationary cost increases in materials, commodities, services, wages, energy, fuel and transportation, unfavorable deleveraging of fixed costs resulting from decreased production, a product mix shift toward products with relatively lower margins that remain in relatively stronger demand, and increased promotional costs.

 

The decrease in gross margin for the nine months ended September 30, 2023 is attributable to the aforementioned factors, partially offset by increased pricing.

 

 

Selling and General and Administrative Expenses

 

Selling and general and administrative expenses data for the three months ended (dollars in millions):

 

   September 30,
2023
  October 1,
2022
  Change  % Change
Selling expenses  $8.7   $8.8   $(0.1)   (1.1%)
                     
General and administrative expenses   9.7    10.2    (0.5)   (5.0%)
                     
Total operating expenses  $18.4   $19.0   $(0.6)   (3.2%)
                     

The decrease in selling expenses for the three months ended September 30, 2023 was primarily attributable to the decreased shipping costs as a result of the decrease in sales for the period, partially offset by increased advertising and promotional activity.

 

The decrease in general, and administrative expenses for the three months ended September 30, 2023 was primarily attributable to decreased professional service costs and decreased incentive compensation.

 

23 

 

Selling and general and administrative expenses data for the nine months ended (dollars in millions):

 

   September 30,
2023
  October 1,
2022
  Change  % Change
Selling expenses  $27.7   $25.8   $1.9    7.3% 
                     
General and administrative expenses   31.9    30.9    1.0    3.1% 
                     
Total operating expenses  $59.6   $56.7   $2.9    5.0% 
                     

The increase in selling expenses for the nine months ended September 30, 2023 was primarily attributable to the resumption of trade show participation costs, travel expenditures, and advertising, some of which had been deferred in 2022 due to COVID-19 restrictions, partially offset by decreased sales volume.

 

The increase in general, and administrative expenses for the nine months ended September 30, 2023 was primarily attributable to increased professional service costs, partially offset by decreased incentive compensation.

 

 

Other Income

 

Other income data for the three months ended (dollars in millions):

 

   September 30,
2023
  October 1,
2022
  Change  % Change
                     
Other income  $1.8   $1.1   $0.7    55.7% 
                     

The increase in other income for the three months ended September 30, 2023 was the result of increases in interest income, partially offset by decreased royalty and miscellaneous income.

 

Other income data for the nine months ended (dollars in millions):

 

   September 30,
2023
  October 1,
2022
  Change  % Change
                     
Other income  $5.1   $2.8   $2.3    78.0% 

 

The increase in other income for the nine months ended September 30, 2023 was the result of increases in interest income, partially offset by decreased royalty and miscellaneous income.

 

The Company's 2023 and 2022 effective tax rates differ from the statutory federal tax rate due principally to research and development tax credits, state income taxes and the nondeductibility of certain executive compensation. The Company’s effective income tax rate was 8.1% and 18.9% for the three and nine months ended September 30, 2023, respectively. The Company’s effective income tax rate was 12.4% and 19.9% for the three and nine months ended October 1, 2022, respectively.

 

24 

 

Non-GAAP Financial Measures

In an effort to provide investors with additional information regarding its financial results, the Company refers to various United States generally accepted accounting principles (“GAAP”) financial measures and two non-GAAP financial measures, EBITDA and EBITDA margin, which management believes provides useful information to investors. These non-GAAP financial measures may not be comparable to similarly titled financial measures being disclosed by other companies. In addition, the Company believes that the non-GAAP financial measures should be considered in addition to, and not in lieu of, GAAP financial measures. The Company believes that EBITDA and EBITDA margin are useful to understanding its operating results and the ongoing performance of its underlying business, as EBITDA provides information on the Company’s ability to meet its capital expenditure and working capital requirements, and is also an indicator of profitability. The Company believes that this reporting provides better transparency and comparability to its operating results. The Company uses both GAAP and non-GAAP financial measures to evaluate the Company’s financial performance.

 

EBITDA is defined as earnings before interest, taxes, and depreciation and amortization. The Company calculates this by adding the amount of interest expense, income tax expense, and depreciation and amortization expenses that have been deducted from net income back into net income, and subtracting the amount of interest income that was included in net income from net income to arrive at EBITDA. The Company calculates EBITDA margin by dividing EBITDA by total net sales.

 

EBITDA was $13.3 million for the three months ended September 30, 2023, a decrease of 50.8% from $27.0 million in the comparable prior year period.

 

For the nine months ended September 30, 2023 EBITDA was $62.4 million, a decrease of 41.1% from $106.0 million in the comparable prior year period.

Non-GAAP Reconciliation – EBITDA

EBITDA

(Unaudited, dollars in thousands)

 

   Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
             
Net income  $7,431   $18,389   $37,966   $69,378 
                     
Income tax expense   658    2,602    8,848    17,236 
Depreciation and amortization expense   6,530    6,656    19,576    20,120 
Interest income   (1,454)   (730)   (4,147)   (951)
Interest expense   122    88    177    205 
EBITDA  $13,287   $27,005   $62,420   $105,988 
EBITDA margin   11.0%    19.4%    15.1%    23.7% 

 

25 

 

Financial Condition

 

Liquidity and Capital Resources

 

At the end of the third quarter of 2023, the Company’s cash and short-term investments totaled $120.0 million. Pre-LIFO working capital of $277.8 million, less the LIFO reserve of $65.0 million, resulted in working capital of $212.8 million and a current ratio of 4.5 to 1.

 

Operations

 

Cash provided by operating activities was $17.3 million for the nine months ended September 30, 2023, compared to $50.3 million for the comparable prior year period. The decrease in cash provided in the nine months ended September 30, 2023 is primarily attributable to the decrease in net income and the increase in prepaid expenses and other assets in the nine months ended September 30, 2023, partially offset by the decrease in accounts receivable in the nine months ended September 30, 2023.

 

Third parties supply the Company with various raw materials for its firearms and castings, such as steel, fabricated steel components, walnut, birch, beech, maple and laminated lumber for rifle stocks, wax, ceramic material, metal alloys, various synthetic products and other component parts. A limited supply of these materials in the marketplace can result in increases to purchase prices and adversely affect production levels. If market conditions result in a significant prolonged inflation of certain prices or if adequate quantities of raw materials cannot be obtained, the Company’s manufacturing processes could be interrupted and the Company’s financial condition or results of operations could be materially adversely affected.

 

Investing and Financing

 

Capital expenditures for the nine months ended September 30, 2023 totaled $11.6 million, a decrease from $17.2 million in the comparable prior year period. In 2023, the Company expects capital expenditures related to new product introductions and upgrades to our manufacturing equipment and facilities to total approximately $20 million. Due to market conditions and business circumstances, actual capital expenditures could vary significantly from the projected amount. The Company finances, and intends to continue to finance, all of these activities with funds provided by operations and current cash and cash equivalents.

 

Dividends of $107.8 million were paid during the nine months ended September 30, 2023. This included $88.3 million paid in January 2023 for a $5.00 per share special dividend declared by the Board of Directors in November 2022. The Company has financed its dividends with cash provided by operations and current cash. The quarterly dividend varies every quarter because the Company pays a percentage of earnings rather than a fixed amount per share. The Company’s practice is to pay a dividend of approximately 40% of net income.

 

On October 27, 2023, the Company’s Board of Directors authorized a dividend of 17¢ per share to shareholders of record on November 15, 2023, payable on November 29, 2023. The payment of future dividends depends on many factors, including internal estimates of future performance, then-current cash and short-term investments, and the Company’s need for funds.

 

As of September 30, 2023, the Company had $88.1 million of United States Treasury instruments which mature within one year. The Company also invests available cash in a bank-managed money market fund that invests exclusively in United States Treasury instruments which mature within one year. At September 30, 2023, the Company’s investment in this money market fund totaled $18.4 million.

 

26 

 

The Company did not purchase any shares of its common stock during the nine months ended September 30, 2023. As of September 30, 2023, $86.6 million remained authorized for future stock repurchases.

 

Based on its unencumbered assets, the Company believes it has the ability to raise cash through the issuance of short-term or long-term debt. The Company’s unsecured $40 million credit facility, which expires on January 7, 2025, was unused at September 30, 2023.

 

Other Operational Matters

 

In the normal course of its manufacturing operations, the Company is subject to occasional governmental proceedings and orders pertaining to workplace safety, firearms serial number tracking and control, waste disposal, air emissions and water discharges into the environment. The Company believes that it is generally in compliance with applicable Bureau of Alcohol, Tobacco, Firearms & Explosives, environmental, and safety regulations and the outcome of any proceedings or orders will not have a material adverse effect on the financial position or results of operations of the Company. If these regulations become more stringent in the future and the Company is not able to comply with them, such noncompliance could have a material adverse impact on the Company.

 

The Company has 15 independent distributors that service the domestic commercial market. Additionally, the Company has 45 and 25 distributors servicing the export and law enforcement markets, respectively.

 

The Company self-insures a significant amount of its product liability, workers’ compensation, medical, and other insurance. It also carries significant deductible amounts on various insurance policies.

 

The Company expects to realize its deferred tax assets through tax deductions against future taxable income.

 

Impact of Covid-19

 

The global outbreak of the coronavirus disease 2019 (“COVID-19”) was declared a pandemic by the World Health Organization and a national emergency by the U.S. Government in March 2020. The Company has taken many proactive steps to maintain the health and safety of its employees and to mitigate the impact on its business. During the nine month period ended September 30, 2023, the Company did not experience a significant adverse impact on its business from COVID-19 or related government restrictions. The Company cannot predict the extent to which its business, results of operations, financial condition, or cash flows will ultimately be impacted by COVID-19.

 

Adjustments to Critical Accounting Policies

 

The Company has not made any adjustments to its critical accounting estimates and assumptions described in the Company’s 2022 Annual Report on Form 10-K filed on February 22, 2023, or the judgments affecting the application of those estimates and assumptions.

 

27 

 

Forward-Looking Statements and Projections

 

The Company may, from time to time, make forward-looking statements and projections concerning future expectations. Such statements are based on current expectations and are subject to certain qualifying risks and uncertainties, such as market demand, sales levels of firearms, anticipated castings sales and earnings, the need for external financing for operations or capital expenditures, the results of pending litigation against the Company, the impact of future firearms control and environmental legislation, the impact of COVID-19, and accounting estimates, any one or more of which could cause actual results to differ materially from those projected. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to publish revised forward-looking statements to reflect events or circumstances after the date such forward-looking statements are made or to reflect the occurrence of subsequent unanticipated events.

 

 

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The interest rate market risk implicit to the Company at any given time is typically low, as the Company does not have significant exposure to changing interest rates on invested cash. There has been no material change in the Company’s exposure to interest rate risks during the three months ended September 30, 2023.

 

 

ITEM 4.CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (the “Disclosure Controls and Procedures”), as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 30, 2023.

 

Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2023, such Disclosure Controls and Procedures are effective to ensure that information required to be disclosed in the Company’s periodic reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer or persons performing similar functions, as appropriate, to allow timely decisions regarding disclosure.

 

The Company’s Chief Executive Officer and Chief Financial Officer have further concluded that, as of September 30, 2023, there have been no material changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.   The Company has not experienced any material impact to its internal controls over financial reporting as a result of the COVID-19 pandemic.

 

28 

 

The effectiveness of any system of internal controls and procedures is subject to certain limitations, and, as a result, there can be no assurance that the Disclosure Controls and Procedures will detect all errors or fraud. An internal control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the internal control system will be attained.

 

 

PART II. OTHER INFORMATION

 

 

ITEM 1.LEGAL PROCEEDINGS

 

The nature of the legal proceedings against the Company is discussed at Note 13 to the financial statements, which are included in this Form 10-Q.

 

The Company has reported all cases instituted against it through July 1, 2023, and the results of those cases, where terminated, to the SEC on its previous Form 10-Q and 10-K reports, to which reference is hereby made.

 

There were no lawsuits formally instituted against the Company during the three months ending September 30, 2023.

 

 

ITEM 1A.RISK FACTORS

 

During the three months ended September 30, 2023, there were no material changes in the Company’s risk factors from the information provided in Item 1A. Risk Factors included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

 

 

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Not applicable

 

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

Not applicable

 

 

ITEM 4.MINE SAFETY DISCLOSURES

 

Not applicable

 

29 

 

ITEM 5.OTHER INFORMATION

 

Rule 10b5-1 Trading Plans

 

During the three months ended September 30, 2023, none of the Company’s Section 16 officers or directors adopted or terminated contracts, instructions, or written plans for the purchase or sale of Company securities.

 

Due to an administrative oversight, a plan for the purchase and sale of the Company’s securities which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (“Rule 10b5-1 Plan”) was adopted during the three months ended July 1, 2023 by a Section 16 officer of Company securities was not reported in the Form 10-Q filed with respect to such period. The details of such Rule 10b5-1 Plan are as follows:

 

Name Title Action Date
Adopted
Expiration
Date
Aggregate # of
Securities to be
Purchased/Sold
Michael W. Wilson (1) Vice President of Operations for New Product Development, Product Engineering and Mayodan Manufacturing Adoption of Rule 10b5-1 Plan May 22, 2023 December 31, 2023 2,919

 

(1)Michael W. Wilson, an officer of the Company, entered into a Rule 10b5-1 Plan on May 22, 2023. Mr. Wilson’s Rule 10b5-1 Plan provides for the potential sale of up to 2,919 shares of the Company’s common stock. The Rule 10b5-1 Plan expires on December 31, 2023, or upon the earlier completion of all authorized transactions under such Rule 10b5-1 Plan.

None of the Company’s directors or Section 16 officers adopted or terminated a “non-Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K during the three months ended September 30, 2023.

 

30 

 

ITEM 6.EXHIBITS

 

(a)Exhibits:

 

31.1Certification Pursuant to Rule 13a-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

 

31.2Certification Pursuant to Rule 13a-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

 

32.1Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

 

32.2Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

 

101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

 

101.SCHXBRL Taxonomy Extension Schema Document*

 

101.CALXBRL Taxonomy Extension Calculation Linkbase Document*

 

101.DEFXBRL Taxonomy Extension Definition Linkbase Document*

 

101.LABXBRL Taxonomy Extension Label Linkbase Document*

 

101.PREXBRL Taxonomy Extension Presentation Linkbase Document*

 

104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

*Filed herewith

**Furnished herewith

31 

 

 

 

 

STURM, RUGER & COMPANY, INC.

 

FORM 10-Q FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2023

 

SIGNATURES

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

    STURM, RUGER & COMPANY, INC.
     
     
     
     
Date:  November 1, 2023   S/THOMAS A. DINEEN
   

Thomas A. Dineen

Principal Financial Officer,

Principal Accounting Officer,

Senior Vice President, Treasurer and Chief Financial Officer

     
     
     
     

 

 

 

32 

 

 

50000 50000 false --12-31 Q3 0000095029 0000095029 2023-01-01 2023-09-30 0000095029 2023-10-20 0000095029 2023-09-30 0000095029 2022-12-31 0000095029 us-gaap:NonvotingCommonStockMember 2023-09-30 0000095029 us-gaap:NonvotingCommonStockMember 2022-12-31 0000095029 rgr:FirearmsMember 2023-07-01 2023-09-30 0000095029 rgr:FirearmsMember 2022-07-01 2022-10-01 0000095029 rgr:FirearmsMember 2023-01-01 2023-09-30 0000095029 rgr:FirearmsMember 2022-01-02 2022-10-01 0000095029 rgr:UnaffiliatedCastingsMember 2023-07-01 2023-09-30 0000095029 rgr:UnaffiliatedCastingsMember 2022-07-01 2022-10-01 0000095029 rgr:UnaffiliatedCastingsMember 2023-01-01 2023-09-30 0000095029 rgr:UnaffiliatedCastingsMember 2022-01-02 2022-10-01 0000095029 2023-07-01 2023-09-30 0000095029 2022-07-01 2022-10-01 0000095029 2022-01-02 2022-10-01 0000095029 us-gaap:CommonStockMember 2022-12-31 0000095029 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000095029 us-gaap:RetainedEarningsMember 2022-12-31 0000095029 us-gaap:TreasuryStockCommonMember 2022-12-31 0000095029 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0000095029 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0000095029 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0000095029 us-gaap:CommonStockMember 2023-09-30 0000095029 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000095029 us-gaap:RetainedEarningsMember 2023-09-30 0000095029 us-gaap:TreasuryStockCommonMember 2023-09-30 0000095029 2022-01-01 0000095029 2022-10-01 0000095029 rgr:TotalSalesMember us-gaap:CustomerConcentrationRiskMember rgr:FirearmsMember 2023-01-01 2023-09-30 0000095029 us-gaap:NonUsMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0000095029 rgr:TotalSalesMember us-gaap:CustomerConcentrationRiskMember rgr:UnaffiliatedCastingsMember 2023-01-01 2023-09-30 0000095029 2023-06-30 0000095029 2022-06-30 0000095029 2023-07-01 0000095029 us-gaap:LineOfCreditMember 2022-01-07 0000095029 us-gaap:LineOfCreditMember 2022-01-02 2022-01-07 0000095029 us-gaap:LineOfCreditMember 2023-01-01 2023-09-30 0000095029 2022-07-02 2022-10-01 0000095029 rgr:StockIncentivePlan2017Member 2017-05-31 0000095029 rgr:StockIncentivePlan2023Member 2023-06-30 0000095029 rgr:StockIncentivePlan2023Member 2023-09-30 0000095029 rgr:StockIncentivePlan2017Member 2023-09-30 0000095029 rgr:CastingsMember rgr:UnaffiliatedCastingsMember 2023-07-01 2023-09-30 0000095029 rgr:CastingsMember rgr:UnaffiliatedCastingsMember 2022-07-01 2022-10-01 0000095029 rgr:CastingsMember rgr:UnaffiliatedCastingsMember 2023-01-01 2023-09-30 0000095029 rgr:CastingsMember rgr:UnaffiliatedCastingsMember 2022-01-02 2022-10-01 0000095029 rgr:CastingsMember rgr:IntersegmentMember 2023-07-01 2023-09-30 0000095029 rgr:CastingsMember rgr:IntersegmentMember 2022-07-01 2022-10-01 0000095029 rgr:CastingsMember rgr:IntersegmentMember 2023-01-01 2023-09-30 0000095029 rgr:CastingsMember rgr:IntersegmentMember 2022-01-02 2022-10-01 0000095029 rgr:CastingsMember 2023-07-01 2023-09-30 0000095029 rgr:CastingsMember 2022-07-01 2022-10-01 0000095029 rgr:CastingsMember 2023-01-01 2023-09-30 0000095029 rgr:CastingsMember 2022-01-02 2022-10-01 0000095029 rgr:EliminationsMember 2023-07-01 2023-09-30 0000095029 rgr:EliminationsMember 2022-07-01 2022-10-01 0000095029 rgr:EliminationsMember 2023-01-01 2023-09-30 0000095029 rgr:EliminationsMember 2022-01-02 2022-10-01 0000095029 rgr:FirearmsMember 2023-07-01 2023-09-30 0000095029 rgr:FirearmsMember 2022-07-01 2022-10-01 0000095029 rgr:FirearmsMember 2023-01-01 2023-09-30 0000095029 rgr:FirearmsMember 2022-01-02 2022-10-01 0000095029 rgr:UnaffiliatedCastingsMember 2023-07-01 2023-09-30 0000095029 rgr:UnaffiliatedCastingsMember 2022-07-01 2022-10-01 0000095029 rgr:UnaffiliatedCastingsMember 2023-01-01 2023-09-30 0000095029 rgr:UnaffiliatedCastingsMember 2022-01-02 2022-10-01 0000095029 rgr:CorporatesMember 2023-07-01 2023-09-30 0000095029 rgr:CorporatesMember 2022-07-01 2022-10-01 0000095029 rgr:CorporatesMember 2023-01-01 2023-09-30 0000095029 rgr:CorporatesMember 2022-01-02 2022-10-01 0000095029 rgr:FirearmsMember 2023-09-30 0000095029 rgr:FirearmsMember 2022-12-31 0000095029 rgr:CastingsMember 2023-09-30 0000095029 rgr:CastingsMember 2022-12-31 0000095029 rgr:CorporatesMember 2023-09-30 0000095029 rgr:CorporatesMember 2022-12-31 0000095029 rgr:NationalRifleAssociationMember 2023-07-01 2023-09-30 0000095029 rgr:NationalRifleAssociationMember 2023-01-01 2023-09-30 0000095029 rgr:NationalRifleAssociationMember 2022-07-02 2022-10-01 0000095029 rgr:NationalRifleAssociationMember 2022-01-02 2022-10-01 0000095029 rgr:NationalShootingSportsFoundationMember 2023-07-01 2023-09-30 0000095029 rgr:NationalShootingSportsFoundationMember 2023-01-01 2023-09-30 0000095029 rgr:NationalShootingSportsFoundationMember 2022-07-02 2022-10-01 0000095029 rgr:NationalShootingSportsFoundationMember 2022-01-02 2022-10-01 0000095029 2000-07-01 2000-07-10 0000095029 2021-01-01 2021-12-31 0000095029 2022-01-01 2022-12-31 0000095029 us-gaap:SubsequentEventMember 2023-10-27 0000095029 rgr:MichaelWWilsonMember 2023-01-01 2023-09-30 0000095029 rgr:MichaelWWilsonMember 2023-09-30 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure rgr:segments

EXHIBIT 31.1

 

CERTIFICATION

 

 

I, Christopher J. Killoy, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q (the “Report”) of Sturm, Ruger & Company, Inc. (the “Registrant”);

 

2.Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report;

 

4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and

 

d)Disclosed in this Report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

 

 

5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

 

Date: November 1, 2023

 

 

 

S/CHRISTOPHER J. KILLOY                        

Christopher J. Killoy

Chief Executive Officer

 

 

 

 

 

 

EXHIBIT 31.2

 

CERTIFICATION

 

 

I, Thomas A. Dineen, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q (the “Report”) of Sturm, Ruger & Company, Inc. (the “Registrant”);

 

2.Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this Report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this Report;

 

4.The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this Report is being prepared;

 

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this Report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this Report based on such evaluation; and

 

d)Disclosed in this Report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and

 

 

5.The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting.

 

 

Date: November 1, 2023

 

 

 

S/THOMAS A. DINEEN                        

Thomas A. Dineen

Senior Vice President, Treasurer and

Chief Financial Officer

 

 

 

EXHIBIT 32.1

 

 

 

 

Certification Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

 

In connection with the Quarterly Report on Form 10-Q of Sturm, Ruger & Company, Inc. (the “Company”) for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher J. Killoy, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respect, the financial condition and results of operations of the Company.

 

 

 

 

 

Date:  November 1, 2023 S/CHRISTOPHER J. KILLOY
  Christopher J. Killoy
  Chief Executive Officer

 

 

 

 

 

 

 

A signed original of this statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

EXHIBIT 32.2

 

 

 

Certification Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

 

In connection with the Quarterly Report on Form 10-Q of Sturm, Ruger & Company, Inc. (the “Company”) for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas A. Dineen, Senior Vice President, Treasurer and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respect, the financial condition and results of operations of the Company.

 

 

 

 

 

 

Date:  November 1, 2023 S/THOMAS A. DINEEN
  Thomas A. Dineen
  Senior Vice President, Treasurer and
  Chief Financial Officer

 

 

 

 

 

 

 

A signed original of this statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

v3.23.3
Cover - shares
9 Months Ended
Sep. 30, 2023
Oct. 20, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Entity Information [Line Items]    
Entity Registrant Name STURM, RUGER & COMPANY, INC.  
Entity Central Index Key 0000095029  
Entity File Number 1-10435  
Entity Tax Identification Number 06-0633559  
Entity Incorporation, State or Country Code DE  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One One Lacey Place  
Entity Address, City or Town Southport  
Entity Address, State or Province CT  
Entity Address, Postal Zip Code 06890  
Entity Phone Fax Numbers [Line Items]    
City Area Code (203)  
Local Phone Number 259-7843  
Entity Listings [Line Items]    
Title of 12(b) Security Common Stock, $1 par value  
Trading Symbol RGR  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   17,722,682
v3.23.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash $ 13,559 $ 65,173
Short-term investments 106,451 159,132
Trade receivables, net 59,899 65,449
Gross inventories (Note 4) 150,021 129,294
Less LIFO reserve (64,969) (59,489)
Less excess and obsolescence reserve (5,781) (4,812)
Net inventories 79,271 64,993
Prepaid expenses and other current assets 14,780 7,091
Total Current Assets 273,960 361,838
Property, plant and equipment 458,332 447,126
Less allowances for depreciation (388,531) (370,273)
Net property, plant and equipment 69,801 76,853
Deferred income taxes 10,167 6,109
Other assets 46,422 39,963
Total Assets 400,350 484,763
Current Liabilities    
Trade accounts payable and accrued expenses 29,736 35,658
Dividends payable 88,343
Contract liabilities with customers (Note 3) 1,436 1,031
Product liability 406 235
Employee compensation and benefits 23,142 30,160
Workers’ compensation 6,467 6,469
Income taxes payable 1,171
Total Current Liabilities 61,187 163,067
Employee compensation 1,484 1,846
Product liability accrual 46 73
Lease liability (Note 5) 2,328 3,039
Contingent liabilities (Note 13)
Stockholders’ Equity    
Common stock value 24,437 24,378
Additional paid-in capital 45,828 45,075
Retained earnings 410,852 393,097
Treasury stock value (145,812) (145,812)
Total Stockholders’ Equity 335,305 316,738
Total Liabilities and Stockholders’ Equity 400,350 484,763
non-voting Common Stock    
Stockholders’ Equity    
Common stock value
v3.23.3
Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Common stock, par value (in Dollars per share) $ 1 $ 1
Common stock, shares authorized 40,000,000 40,000,000
Common stock, shares issued 24,437,020 24,378,568
Common stock, shares outstanding 17,722,682 17,664,230
Treasury stock shares 6,714,338 6,714,338
Nonvoting Common Stock    
Common stock, par value (in Dollars per share) $ 1 $ 1
Common stock, shares authorized 50,000 50,000
Common stock, shares issued
v3.23.3
Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Total net sales $ 120,893 $ 139,390 $ 413,150 $ 446,618
Cost of products sold 96,165 100,521 311,788 306,087
Gross profit 24,728 38,869 101,362 140,531
Operating expenses:        
Selling 8,669 8,763 27,702 25,828
General and administrative 9,733 10,247 31,898 30,927
Total operating expenses 18,402 19,010 59,600 56,755
Operating income 6,326 19,859 41,762 83,776
Other income:        
Interest income 1,454 730 4,147 951
Interest expense (122) (88) (177) (205)
Other income, net 431 490 1,082 2,092
Total other income, net 1,763 1,132 5,052 2,838
Income before income taxes 8,089 20,991 46,814 86,614
Income taxes 658 2,602 8,848 17,236
Net income and comprehensive income $ 7,431 $ 18,389 $ 37,966 $ 69,378
Basic earnings per share (in Dollars per share) $ 0.42 $ 1.04 $ 2.14 $ 3.93
Diluted earnings per share (in Dollars per share) $ 0.42 $ 1.03 $ 2.13 $ 3.9
Weighted average number of common shares outstanding - Basic (in Shares) 17,722,682 17,668,435 17,705,280 17,643,473
Weighted average number of common shares outstanding - Diluted (in Shares) 17,889,089 17,825,797 17,828,710 17,770,120
Cash dividends per share (in Dollars per share) $ 0.36 $ 0.47 $ 6.1 $ 2.01
Net firearms sales        
Total net sales $ 120,368 $ 138,771 $ 411,114 $ 444,615
Net castings sales        
Total net sales $ 525 $ 619 $ 2,036 $ 2,003
v3.23.3
Condensed Consolidated Statement of Stockholders’ Equity (Unaudited) - 9 months ended Sep. 30, 2023 - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Retained Earnings
Treasury Stock
Total
Balance at Dec. 31, 2022 $ 24,378 $ 45,075 $ 393,097 $ (145,812) $ 316,738
Net income and comprehensive income     37,966   37,966
Common stock issued – compensation plans 59 (59)    
Vesting of RSUs   (2,156)     (2,156)
Dividends paid     (19,462)   (19,462)
Unpaid dividends accrued     (749)   (749)
Recognition of stock-based compensation expense   2,968     2,968
Balance at Sep. 30, 2023 $ 24,437 $ 45,828 $ 410,852 $ (145,812) $ 335,305
v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Operating Activities    
Net income $ 37,966 $ 69,378
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 19,576 20,120
Stock-based compensation 2,968 5,053
(Gain) loss on sale of assets (4) 15
Deferred income taxes (4,058) (1,908)
Changes in operating assets and liabilities:    
Trade receivables 5,550 (4,326)
Inventories (14,278) (17,655)
Trade accounts payable and accrued expenses (5,967) (5,315)
Contract liability with customers 405
Employee compensation and benefits (8,129) (11,774)
Product liability 144 (340)
Prepaid expenses, other assets and other liabilities (15,704) (2,985)
Income taxes payable (1,171)
Cash provided by operating activities 17,298 50,263
Investing Activities    
Property, plant and equipment additions (11,637) (17,206)
Proceeds from sale of assets 5 41
Purchases of short-term investments (141,410) (200,378)
Proceeds from maturities of short-term investments 194,091 235,041
Cash provided by investing activities 41,049 17,498
Financing Activities    
Remittance of taxes withheld from employees related to share-based compensation (2,156) (3,371)
Repurchase of common stock (107)
Dividends paid (107,805) (35,474)
Cash used for financing activities (109,961) (38,952)
(Decrease) increase in cash and cash equivalents (51,614) 28,809
Cash and cash equivalents at beginning of period 65,173 21,044
Cash and cash equivalents at end of period $ 13,559 $ 49,853
v3.23.3
Basis of Presentation
9 Months Ended
Sep. 30, 2023
Basis of Presentation [Abstract]  
BASIS OF PRESENTATION

NOTE 1 - BASIS OF PRESENTATION

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the results of the interim periods. Operating results for the three and nine months ended September 30, 2023 may not be indicative of the results to be expected for the full year ending December 31, 2023. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

v3.23.3
Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Basis of Presentation [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES

 

Organization:

 

Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales are from firearms. Export sales accounted for approximately 7% of total sales for the nine month periods ended September 30, 2023 and October 1, 2022. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors, principally to the commercial sporting market.

 

The Company also manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and for sale to unaffiliated, third-party customers. Approximately 1% of sales are from the castings segment.

 

Principles of Consolidation:

 

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany accounts and transactions have been eliminated.

 

Revenue Recognition:

 

The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”). Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company’s products from the independent distributors. The fulfillment of these no charge products is the Company’s responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales.

 

Fair Value of Financial Instruments:

 

The carrying amounts of financial instruments, including cash, short-term investments, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to the short-term maturity of these items.

 

The Company’s short-term investments consist of United States Treasury instruments, which mature within one year, and investments in a bank-managed money market fund that invests exclusively in United States Treasury obligations and is valued at the net asset value ("NAV") daily closing price, as reported by the fund, based on the amortized cost of the fund’s securities. The NAV is used as a practical expedient to estimate fair value. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV.

 

Use of Estimates:

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

v3.23.3
Revenue Recognition and Contracts with Customers
9 Months Ended
Sep. 30, 2023
Revenue Recognition and Contracts with Customers [Abstract]  
REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

NOTE 3 - REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

 

The impact of ASC 606 on revenue recognized during the three and nine months ended September 30, 2023 and October 1, 2022 is as follows:

 

   Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
                 
Contract liabilities with customers at beginning of period  $100   $
   $1,031   $
 
                     
Revenue deferred   1,468    
    1,680    
 
                     
Revenue recognized   (132)   
    (1,275)   
 
                     
Contract liabilities with customers at end of period  $1,436   $
   $1,436   $
 

 

As more fully described in the Revenue Recognition section of Note 2, the deferral of revenue and subsequent recognition thereof relates to certain of the Company’s sales promotion programs that include the future shipment of free products. The Company expects the remaining deferred revenue from this contract liability with customers to be recognized in the fourth quarter of 2023.

 

Practical Expedients and Exemptions

 

The Company has elected to account for shipping and handling activities that occur after control of the related product transfers to the customer as fulfillment activities that are recognized upon shipment of the goods.

v3.23.3
Inventories
9 Months Ended
Sep. 30, 2023
Inventories [Abstract]  
INVENTORIES

NOTE 4 - INVENTORIES

 

Inventories are valued using the last-in, first-out (LIFO) method. An actual valuation of inventory under the LIFO method can be made only at the end of each year based on the inventory levels and costs existing at that time. Accordingly, interim LIFO calculations must necessarily be based on management's estimates of expected year-end inventory levels and costs. Because these are subject to many factors beyond management's control, interim results are subject to the final year-end LIFO inventory valuation.

 

Inventories consist of the following:

 

   September 30, 2023   December 31, 2022 
Inventory at FIFO          
Finished products  $31,907   $23,573 
Materials and work in process   118,114    105,721 
Gross inventories   150,021    129,294 
Less: LIFO reserve   (64,969)   (59,489)
Less: excess and obsolescence reserve   (5,781)   (4,812)
Net inventories  $79,271   $64,993 
v3.23.3
Leased Assets
9 Months Ended
Sep. 30, 2023
Leased Assets [Abstract]  
LEASED ASSETS

NOTE 5 - LEASED ASSETS

 

The Company leases certain of its real estate and equipment. The Company has evaluated all its leases and determined that all are operating leases under the definitions of the guidance of ASU 2016-02, Leases (Topic 842). The Company’s lease agreements generally do not require material variable lease payments, residual value guarantees or restrictive covenants.

 

Under the provisions of ASU 2016-02, the Company records right-of-use assets equal to the present value of the contractual liability for future lease payments. The table below presents the right-of- use assets and related lease liabilities recognized on the Condensed Consolidated Balance Sheet as of September 30, 2023:

 

   Balance Sheet Line Item  September 30, 2023 
Right-of-use assets  Other assets  $2,926 
         
Operating lease liabilities        
         
Current portion  Trade accounts payable and accrued expenses  $598 
         
Noncurrent portion  Lease liabilities   2,328 
         
Total operating lease liabilities     $2,926 

 

The depreciable lives of right-of-use assets are limited by the lease term and are amortized on a straight line basis over the life of the lease.

 

The Company’s leases generally do not provide an implicit interest rate, and therefore the Company calculates an incremental borrowing rate to determine the present value of its operating lease liabilities. The following table reconciles the undiscounted future minimum lease payments to the total operating lease liabilities recognized on the Condensed Consolidated Balance Sheet as of September 30, 2023:

 

Remainder of 2023  $200 
2024   808 
2025   702 
2026   705 
2027   229 
Thereafter   1,120 
Total undiscounted future minimum lease payments   3,764 
Less: Difference between undiscounted lease payments & the present value of future lease payments   (838)
Total operating lease liabilities  $2,926 

 

Certain of the Company’s lease agreements contain renewal options at the Company’s discretion. The Company does not recognize right-of-use assets or lease liabilities for leases of one year or less or for renewal periods unless it is reasonably certain that the Company will exercise the renewal option at the inception of the lease or when a triggering event occurs. The Company’s weighted average remaining lease term for operating leases as of September 30, 2023 is 8.1 years.

v3.23.3
Line of Credit
9 Months Ended
Sep. 30, 2023
Line of Credit [Abstract]  
LINE OF CREDIT

NOTE 6 - LINE OF CREDIT

 

On January 7, 2022, the Company entered into a $40 million unsecured revolving line of credit agreement with a bank that expires January 7, 2025. Borrowings under this new facility bear interest at either 1) the Bloomberg short-Term Bank Yield Index – 1 month plus 150 basis points, or 2) a fluctuating rate per annum equal to the greater of (i) the Bank’s prime rate or (ii) the federal funds rate plus 50 basis points. The Company is also charged one-quarter of a percent (0.25%) per year on the unused portion. At September 30, 2023, the Company was in compliance with the terms and covenants of the credit facility and the line of credit was unused.

v3.23.3
Employee Benefit Plans
9 Months Ended
Sep. 30, 2023
Employee Benefit Plans [Abstract]  
EMPLOYEE BENEFIT PLANS

NOTE 7 - EMPLOYEE BENEFIT PLANS

 

The Company sponsors a 401(k) plan that covers substantially all employees. The Company matches a certain portion of employee contributions using the safe harbor guidelines contained in the Internal Revenue Code. Expenses related to these matching contributions totaled $1.0 million and $3.7 million for the three and nine months ended September 30, 2023, respectively, and $0.9 million and $3.1 million for the three and nine months ended October 1, 2022, respectively. The Company plans to contribute approximately $1.0 million to the plan in matching employee contributions during the remainder of 2023.

 

In addition, the Company provided supplemental discretionary contributions to the 401(k) plan totaling $1.6 million and $5.3 million for the three and nine months ended September 30, 2023, respectively, and $1.5 million and $5.4 million for the three and nine months ended October 1, 2022, respectively. The Company plans to contribute approximately $1.6 million in supplemental contributions to the plan during the remainder of 2023.

v3.23.3
Income Taxes
9 Months Ended
Sep. 30, 2023
Income Taxes [Abstract]  
INCOME TAXES

NOTE 8 - INCOME TAXES

 

The Company's 2023 and 2022 effective tax rates differ from the statutory federal tax rate due principally to the availability of research and development tax credits, state income taxes, and the nondeductibility of certain executive compensation. The Company’s effective income tax rate was 8.1% and 18.9% for the three and nine months ended September 30, 2023, respectively. The Company’s effective income tax rate was 12.4% and 19.9% for the three and nine months October 1, 2022, respectively. The lower effective income tax rates for the three and nine months ended September 30, 2023 resulted from the recognition of higher than anticipated tax credits that were noted when the Company filed its 2022 Federal and state income tax returns.

 

Income tax payments for the three and nine months ended September 30, 2023 totaled $7.3 million and $23.8 million, respectively. Income tax payments for the three and nine months ended October 1, 2022 totaled $6.0 million and $26.6 million, respectively.

 

The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. With few exceptions, the Company is no longer subject to U.S. federal and state income tax examinations by tax authorities for years before 2018.

 

The Company does not believe it has included any “uncertain tax positions” in its federal income tax return or any of the state income tax returns it is currently filing. The Company has made an evaluation of the potential impact of additional state taxes being assessed by jurisdictions in which the Company does not currently consider itself liable. The Company does not anticipate that such additional taxes, if any, would result in a material change to its financial position.

v3.23.3
Earnings Per Share
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
EARNINGS PER SHARE

NOTE 9 - EARNINGS PER SHARE

 

Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the periods indicated:

 

   Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
Numerator:                
Net income  $7,431   $18,389   $37,966   $69,378 
                     
Denominator:                    
Weighted average number of common shares outstanding – Basic   17,722,682    17,668,435    17,705,280    17,643,473 
                     
Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans   166,407    157,362    123,430    126,647 
                     
Weighted average number of common shares outstanding – Diluted   17,889,089    17,825,797    17,828,710    17,770,120 

 

The dilutive effect of outstanding options and restricted stock units is calculated using the treasury stock method. There were no stock options that were anti-dilutive and therefore not included in the diluted earnings per share calculation.

v3.23.3
Compensation Plans
9 Months Ended
Sep. 30, 2023
Compensation Plans [Abstract]  
COMPENSATION PLANS

NOTE 10 - COMPENSATION PLANS

 

In May 2017, the Company’s shareholders approved the 2017 Stock Incentive Plan (the “2017 SIP”) under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors. The Company reserved 750,000 shares for issuance under the 2017 SIP.

 

In June 2023, the Company’s shareholders approved the 2023 Stock Incentive Plan (the “2023 SIP”) under which employees, independent contractors, and non-employee directors may be granted stock options, restricted stock, deferred stock awards, and stock appreciation rights, any of which may or may not require the satisfaction of performance objectives. Vesting requirements are determined by the Compensation Committee of the Board of Directors. The Company reserved 1,000,000 shares for issuance under the 2023 SIP, of which 869,000 shares remain available for future grants as of September 30, 2023. Any shares remaining from the 2017 SIP will be available for future grants under the terms of the 2023 SIP. As of September 30, 2023, 121,034 shares remained unawarded from the 2017 SIP. Since the shareholder approval of the 2023 SIP, no additional awards have been or will be granted under the 2017 SIP. Previously granted and outstanding awards under the 2017 SIP will remain subject to the terms of the 2017 SIP.

 

Restricted Stock Units

 

The Company grants performance-based and retention-based restricted stock units to senior employees. The vesting of the performance-based awards is dependent on the achievement of corporate objectives established by the Compensation Committee of the Board of Directors and a three-year vesting period. The retention-based awards are subject only to a three-year vesting period. There were 113,862 restricted stock units issued during the nine months ended September 30, 2023. Total compensation costs related to these restricted stock units are $6.1 million.

 

Compensation costs related to all outstanding restricted stock units recognized in the statements of income aggregated $1.6 million and $5.0 million for the three and nine months ended September 30, 2023, respectively, and $1.7 million and $5.1 million for the three and nine months ended October 1, 2022, respectively.

v3.23.3
Operating Segment Information
9 Months Ended
Sep. 30, 2023
Operating Segment Information [Abstract]  
OPERATING SEGMENT INFORMATION

NOTE 11 - OPERATING SEGMENT INFORMATION

 

The Company has two reportable segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a select number of independent wholesale distributors primarily located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts.

 

Selected operating segment financial information follows:

 

(in thousands)  Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
Net Sales                    
Firearms  $120,368   $138,771   $411,114   $444,615 
Castings                    
Unaffiliated   525    619    2,036    2,003 
Intersegment   7,947    4,453    25,307    13,781 
    8,472    5,072    27,343    15,784 
Eliminations   (7,947)   (4,453)   (25,307)   (13,781)
   $120,893   $139,390   $413,150   $446,618 
                     
Income (Loss) Before Income Taxes                    
Firearms  $6,108   $21,339   $43,637   $88,130 
Castings   420    (1,029)   (1,178)   (2,754)
Corporate   1,561    681    4,355    1,238 
   $8,089   $20,991   $46,814   $86,614 
                     
Depreciation                    
Firearms  $5,676   $5,815   $17,027   $17,430 
Castings   553    574    1,661    1,736 
   $6,229   $6,389   $18,688   $19,166 
                     
Capital Expenditures                    
Firearms  $6,674   $2,324   $11,456   $15,971 
Castings   90    552    181    1,235 
   $6,764   $2,876   $11,637   $17,206 

 

   September 30,
2023
   December 31,
2022
 
Identifiable Assets          
Firearms  $230,340   $223,301 
Castings   10,137    11,910 
Corporate   159,873    249,552 
   $400,350   $484,763 
Goodwill        
Firearms  $3,055   $3,055 
Castings   209    209 
   $3,264   $3,264 
v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 12 - RELATED PARTY TRANSACTIONS

 

The Company contracts with the National Rifle Association (“NRA”) for some of its promotional and advertising activities. Payments made to the NRA in the three and nine months ended September 30, 2023 totaled $0.1 million and $0.4 million, respectively. Payments made to the NRA in the three and nine months ended October 1, 2022 totaled $0.2 million and $0.4 million, respectively. One of the Company’s Directors also serves as a Director on the Board of the NRA.

 

The Company is a member of the National Shooting Sports Foundation (“NSSF”), the firearm industry trade association.  Payments made to the NSSF in the three and nine month periods ended September 30, 2023 totaled $0.1 million and $0.3 million, respectively.   Payments made to the NSSF in the three and nine months ended October 1, 2022 totaled $0.1 million and $0.2 million, respectively. One of the Company’s Directors also serves on the Board of the NSSF.

v3.23.3
Contingent Liabilities
9 Months Ended
Sep. 30, 2023
Contingent Liabilities [Abstract]  
CONTINGENT LIABILITIES

NOTE 13 - CONTINGENT LIABILITIES

 

As of September 30, 2023, the Company was a defendant in eight (8) lawsuits and is aware of certain other such claims. The lawsuits fall into three categories: municipal litigation, negligence, and unfair trade practices. Each is discussed in turn below.

 

Municipal Litigation

 

Municipal litigation generally includes those cases brought by cities or other governmental entities against firearms manufacturers, distributors and retailers seeking to recover damages allegedly arising out of the misuse of firearms by third parties. There are four lawsuits of this type: the City of Gary, filed in Indiana State Court in 1999; Estados Unidos Mexicanos v. Smith & Wesson, et al., filed in the U.S. District Court for the District of Massachusetts in August 2021; The City of Buffalo, filed in the Supreme Court of the State of New York for Erie County on December 20, 2022; and The City of Rochester, filed in the Supreme Court for the State of New York for Monroe County on December 21, 2022, each of which is described in more detail below.

 

The City of Gary Complaint seeks damages, among other things, for the costs of medical care, police and emergency services, public health services, and other services as well as punitive damages. In addition, nuisance abatement and/or injunctive relief is sought to change the design, manufacture, marketing and distribution practices of the various defendants. The suit alleges, among other claims, negligence in the design of products, public nuisance, negligent distribution and marketing, negligence per se and deceptive advertising. The case does not allege a specific injury to a specific individual as a result of the misuse or use of any of the Company's products. After a long procedural history, during the quarter ended April 3, 2021, the City initiated discovery and the manufacturer defendants reciprocated. Discovery is ongoing.

 

Estados Unidos Mexicanos v. Smith & Wesson Brands, Inc., et al. was filed by the Country of Mexico and names seven defendants, mostly U.S.-based firearms manufacturers, including the Company. The Complaint advances a variety of legal theories including negligence, public nuisance, unjust enrichment, restitution, and others. Plaintiff essentially alleges that Defendants design, manufacture, distribute, market and sell firearms in a way that they know results in the illegal trafficking of firearms into Mexico, where they are used by Mexican drug cartels for criminal activities. Plaintiff seeks injunctive relief and monetary damages. On November 22, 2021, defendants filed a joint Rule 12(b)(6) motion to dismiss the Mexican Government’s complaint. On September 30, 2022, the court entered an order granting defendants’ motion. On October 26, 2022, plaintiff filed a Notice of Appeal and the matter is being briefed before the First Circuit Court of Appeals. Oral argument was held on July 24, 2023.

 

On December 20, 2022, the City of Buffalo, New York filed a lawsuit captioned The City of Buffalo v. Smith & Wesson Brands, Inc., et al. in the New York State Supreme Court for Erie County, New York. The suit names a number of firearm manufacturers, distributors, and retailers as defendants, including the Company, and purports to state causes of action for violations of Sections 898, 349 and 350 of the New York General Business Law, as well as common law public nuisance. Generally, plaintiff alleges that the criminal misuse of firearms in the City of Buffalo is the result of the manufacturing, sales, marketing, and distribution practices of the defendants. Defendants timely removed the matter to the U.S. District Court for the Western District of New York.

 

On December 21, 2022, the City of Rochester, New York filed a lawsuit captioned The City of Rochester v. Smith & Wesson Brands, Inc., et al. in the New York State Supreme Court for Monroe County, New York. The allegations essentially mirror those in The City of Buffalo, discussed in the preceding paragraph. Defendants timely removed the matter to the U.S. District Court for the Western District of New York.

 

Defendants moved to consolidate the The City of Buffalo and The City of Rochester cases for pretrial purposes only. Defendants also moved to stay the cases pending a decision by the Second Circuit Court of Appeals in National Shooting Sports Foundation, Inc. et al. v. James, which challenges the constitutionality of the recently enacted N.Y. Gen. Bus. Law §§ 898-a–e. On June 8, 2023, the court granted defendants’ motions and the cases were consolidated for pretrial purposes and stayed.

 

Negligence

 

Rossiter v. Sturm, Ruger, et al. is a lawsuit arising out of a slip and fall accident by a contract security officer in December 2019. The Complaint was filed in the Superior Court for Sullivan County, New Hampshire on December 13, 2022 and names Pine Hill Construction, a snow removal contractor, as a co-defendant. The Company has tendered the defense of this matter to its insurance carrier and is assisting as required.

 

The Company was named in two purported class action lawsuits arising out of a data breach at Freestyle Solutions, Inc., the vendor who hosted the Company’s ShopRuger.com website at the time of the breach. Jones v. Sturm, Ruger & Co., was filed in the U.S. District Court for Connecticut on October 4, 2022 and Copeland v. Sturm, Ruger & Company, et al. was filed in the U.S. District Court for New Jersey on October 27, 2022. Copeland also named Freestyle Solutions, Inc. as a defendant. By agreement of the parties, Copeland was dismissed, without prejudice, and consolidated with Jones in the pending Connecticut case. On January 20, 2023, five plaintiffs filed an Amended Complaint naming the Company and Freestyle Software, Inc. as defendants. The Complaint alleges causes of action for negligence, breach of implied warranties, and unjust enrichment. The Company filed a Motion to Dismiss on a variety of grounds. The matter has been briefed fully, and a decision is pending.

 

Unfair Trade Practices

 

Estate of Suzanne Fountain v. Sturm, Ruger & Co., Inc., was filed in the Connecticut Superior Court in Stamford and arises out of the criminal shootings at the King Soopers supermarket in Boulder, Colorado on March 22, 2021. On that date, plaintiff’s decedent, Suzanne Fountain, was murdered by 21-year-old Ahmad Al Aliwi Al-Issa. The Complaint alleges that the Company’s advertising and marketing of the Ruger AR-556 pistol violate the Connecticut Unfair Trade Practices Act and were a substantial factor in bringing about the wrongful death of Suzanne Fountain.

 

Estate of Neven Stanisic et al. v. Sturm, Ruger & Co., Inc., was filed in the Connecticut Superior Court in Stamford on behalf of five plaintiffs. Like Estate of Suzanne Fountain, the claims arise from the criminal shootings at the King Soopers supermarket in Boulder, Colorado on March 22, 2021. Plaintiffs’ decedents were murdered by Ahmad Al Aliwi Al-Issa and plaintiffs allege that the Company’s advertising and marketing of the Ruger AR-556 pistol violate the Connecticut Unfair Trade Practices Act and were a substantial factor in causing the wrongful death of plaintiffs’ decedents.

 

The Fountain and Stanisic cases have been consolidated for discovery purposes only and transferred by the court to the Complex Litigation Docket. Plaintiffs sought leave to file an amended complaint, essentially abandoning their negligent marketing allegations and advancing a new theory predicated upon alleged violations of the Gun Control Act and National Firearms Act. Over the Company’s objections, plaintiffs were permitted to file the amended complaint. The matter was timely removed to the U.S. District Court for the District of Connecticut based upon federal question jurisdiction.

 

Summary of Claimed Damages and Explanation of Product Liability Accruals

 

Punitive damages, as well as compensatory damages, are demanded in certain of the lawsuits and claims. In many instances, the plaintiff does not seek a specified amount of money, though aggregate amounts ultimately sought may exceed product liability accruals and applicable insurance coverage. For product liability claims made after July 10, 2000, coverage is provided on an annual basis for losses exceeding $5 million per claim, or an aggregate maximum loss of $10 million annually, except for certain new claims which might be brought by governments or municipalities after July 10, 2000, which are excluded from coverage.

 

The Company management monitors the status of known claims and the product liability accrual, which includes amounts for asserted and unasserted claims. While it is not possible to forecast the outcome of litigation or the timing of costs, in the opinion of management, after consultation with special and corporate counsel, it is not probable and is unlikely that litigation, including punitive damage claims, will have a material adverse effect on the financial position of the Company, but may have a material impact on the Company's financial results for a particular period.

 

Product liability claim payments are made when appropriate if, as, and when claimants and the Company reach agreement upon an amount to finally resolve all claims. Legal costs are paid as lawsuits and claims develop, the timing of which may vary greatly from case to case. A time schedule cannot be determined in advance with any reliability concerning when payments will be made in any given case.

 

Provision is made for product liability claims based upon many factors related to the severity of the alleged injury and potential liability exposure, based upon prior claim experience. Because the Company's experience in defending these lawsuits and claims is that unfavorable outcomes are typically not probable or estimable, only in rare cases is an accrual established for such costs.

 

In most cases, an accrual is established only for estimated legal defense costs. Product liability accruals are periodically reviewed to reflect then-current estimates of possible liabilities and expenses incurred to date and reasonably anticipated in the future. Threatened product liability claims are reflected in the Company's product liability accrual on the same basis as actual claims; i.e., an accrual is made for reasonably anticipated possible liability and claims handling expenses on an ongoing basis.

 

A range of reasonably possible losses relating to unfavorable outcomes cannot be made. However, in product liability cases in which a dollar amount of damages is claimed, the amount of damages claimed, which totaled $1.1 million at December 31, 2021, is set forth as an indication of possible maximum liability the Company might be required to incur in these cases (regardless of the likelihood or reasonable probability of any or all of this amount being awarded to claimants) as a result of adverse judgments that are sustained on appeal. At December 31, 2022, the total amount claimed specifically in these cases was de minimis.

v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 14 - SUBSEQUENT EVENTS

 

On October 27, 2023, the Board of Directors authorized a dividend of 17¢ per share, for shareholders of record as of November 15, 2023, payable on November 29, 2023.

 

The Company has evaluated events and transactions occurring subsequent to September 30, 2023 and determined that there were no other unreported events or transactions that would have a material impact on the Company’s results of operations or financial position.

v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Pay vs Performance Disclosure        
Net Income (Loss) $ 7,431 $ 18,389 $ 37,966 $ 69,378
v3.23.3
Insider Trading Arrangements
9 Months Ended
Sep. 30, 2023
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Michael W. Wilson [Member]  
Trading Arrangements, by Individual  
Name Michael W. Wilson [1]
Title Vice President of Operations for New Product Development, Product Engineering and Mayodan Manufacturing
Rule 10b5-1 Arrangement Adopted true
Adoption Date May 22, 2023
Termination Date December 31, 2023
Aggregate Available 2,919
[1] Michael W. Wilson, an officer of the Company, entered into a Rule 10b5-1 Plan on May 22, 2023. Mr. Wilson’s Rule 10b5-1 Plan provides for the potential sale of up to 2,919 shares of the Company’s common stock. The Rule 10b5-1 Plan expires on December 31, 2023, or upon the earlier completion of all authorized transactions under such Rule 10b5-1 Plan.
v3.23.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2023
Basis of Presentation [Abstract]  
Organization

Organization:

Sturm, Ruger & Company, Inc. (the “Company”) is principally engaged in the design, manufacture, and sale of firearms to domestic customers. Approximately 99% of sales are from firearms. Export sales accounted for approximately 7% of total sales for the nine month periods ended September 30, 2023 and October 1, 2022. The Company’s design and manufacturing operations are located in the United States and almost all product content is domestic. The Company’s firearms are sold through a select number of independent wholesale distributors, principally to the commercial sporting market.

The Company also manufactures investment castings made from steel alloys and metal injection molding (“MIM”) parts for internal use in its firearms and for sale to unaffiliated, third-party customers. Approximately 1% of sales are from the castings segment.

Principles of Consolidation

Principles of Consolidation:

The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany accounts and transactions have been eliminated.

Revenue Recognition

Revenue Recognition:

The Company recognizes revenue in accordance with the provisions of Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”). Substantially all product sales are sold FOB (free on board) shipping point. Customary payment terms are 2% 30 days, net 40 days. Generally, all performance obligations are satisfied when product is shipped and the customer takes ownership and assumes the risk of loss. In some instances, sales include multiple performance obligations. The most common of these instances relates to sales promotion programs under which downstream customers are entitled to receive no charge products based on their purchases of certain of the Company’s products from the independent distributors. The fulfillment of these no charge products is the Company’s responsibility. In such instances, the Company allocates the revenue of the promotional sales based on the estimated level of participation in the sales promotional program and the timing of the shipment of all of the firearms included in the promotional program, including the no charge firearms. Revenue is recognized proportionally as each performance obligation is satisfied, based on the relative customary price of each product. Customary prices are generally determined based on the prices charged to the independent distributors. The net change in contract liabilities for a given period is reported as an increase or decrease to sales.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments:

The carrying amounts of financial instruments, including cash, short-term investments, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to the short-term maturity of these items.

The Company’s short-term investments consist of United States Treasury instruments, which mature within one year, and investments in a bank-managed money market fund that invests exclusively in United States Treasury obligations and is valued at the net asset value ("NAV") daily closing price, as reported by the fund, based on the amortized cost of the fund’s securities. The NAV is used as a practical expedient to estimate fair value. This practical expedient is not used when it is determined to be probable that the fund will sell the investment for an amount different than the reported NAV.

Use of Estimates

Use of Estimates:

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

v3.23.3
Revenue Recognition and Contracts with Customers (Tables)
9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue Recognized The impact of ASC 606 on revenue recognized during the three and nine months ended September 30, 2023 and October 1, 2022 is as follows:
   Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
                 
Contract liabilities with customers at beginning of period  $100   $
   $1,031   $
 
                     
Revenue deferred   1,468    
    1,680    
 
                     
Revenue recognized   (132)   
    (1,275)   
 
                     
Contract liabilities with customers at end of period  $1,436   $
   $1,436   $
 

 

v3.23.3
Inventories (Tables)
9 Months Ended
Sep. 30, 2023
Inventories [Abstract]  
Schedule of Inventories Inventories consist of the following:
   September 30, 2023   December 31, 2022 
Inventory at FIFO          
Finished products  $31,907   $23,573 
Materials and work in process   118,114    105,721 
Gross inventories   150,021    129,294 
Less: LIFO reserve   (64,969)   (59,489)
Less: excess and obsolescence reserve   (5,781)   (4,812)
Net inventories  $79,271   $64,993 
v3.23.3
Leased Assets (Tables)
9 Months Ended
Sep. 30, 2023
Leased Assets [Abstract]  
Schedule of Right-Of-Use Assets and Related Lease Liabilities Under the provisions of ASU 2016-02, the Company records right-of-use assets equal to the present value of the contractual liability for future lease payments. The table below presents the right-of- use assets and related lease liabilities recognized on the Condensed Consolidated Balance Sheet as of September 30, 2023:
   Balance Sheet Line Item  September 30, 2023 
Right-of-use assets  Other assets  $2,926 
         
Operating lease liabilities        
         
Current portion  Trade accounts payable and accrued expenses  $598 
         
Noncurrent portion  Lease liabilities   2,328 
         
Total operating lease liabilities     $2,926 
Schedule of Operating Lease Liabilities The Company’s leases generally do not provide an implicit interest rate, and therefore the Company calculates an incremental borrowing rate to determine the present value of its operating lease liabilities. The following table reconciles the undiscounted future minimum lease payments to the total operating lease liabilities recognized on the Condensed Consolidated Balance Sheet as of September 30, 2023:
Remainder of 2023  $200 
2024   808 
2025   702 
2026   705 
2027   229 
Thereafter   1,120 
Total undiscounted future minimum lease payments   3,764 
Less: Difference between undiscounted lease payments & the present value of future lease payments   (838)
Total operating lease liabilities  $2,926 
v3.23.3
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of a Reconciliation of the Numerator and Denominator for the Basic and Diluted Earnings Per Share Set forth below is a reconciliation of the numerator and denominator for basic and diluted earnings per share calculations for the periods indicated:
   Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
Numerator:                
Net income  $7,431   $18,389   $37,966   $69,378 
                     
Denominator:                    
Weighted average number of common shares outstanding – Basic   17,722,682    17,668,435    17,705,280    17,643,473 
                     
Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans   166,407    157,362    123,430    126,647 
                     
Weighted average number of common shares outstanding – Diluted   17,889,089    17,825,797    17,828,710    17,770,120 
v3.23.3
Operating Segment Information (Tables)
9 Months Ended
Sep. 30, 2023
Operating Segment Information [Abstract]  
Schedule of Operating Segment Financial Information Selected operating segment financial information follows:
(in thousands)  Three Months Ended   Nine Months Ended 
   September 30,
2023
   October 1,
2022
   September 30,
2023
   October 1,
2022
 
Net Sales                    
Firearms  $120,368   $138,771   $411,114   $444,615 
Castings                    
Unaffiliated   525    619    2,036    2,003 
Intersegment   7,947    4,453    25,307    13,781 
    8,472    5,072    27,343    15,784 
Eliminations   (7,947)   (4,453)   (25,307)   (13,781)
   $120,893   $139,390   $413,150   $446,618 
                     
Income (Loss) Before Income Taxes                    
Firearms  $6,108   $21,339   $43,637   $88,130 
Castings   420    (1,029)   (1,178)   (2,754)
Corporate   1,561    681    4,355    1,238 
   $8,089   $20,991   $46,814   $86,614 
                     
Depreciation                    
Firearms  $5,676   $5,815   $17,027   $17,430 
Castings   553    574    1,661    1,736 
   $6,229   $6,389   $18,688   $19,166 
                     
Capital Expenditures                    
Firearms  $6,674   $2,324   $11,456   $15,971 
Castings   90    552    181    1,235 
   $6,764   $2,876   $11,637   $17,206 

 

   September 30,
2023
   December 31,
2022
 
Identifiable Assets          
Firearms  $230,340   $223,301 
Castings   10,137    11,910 
Corporate   159,873    249,552 
   $400,350   $484,763 
Goodwill        
Firearms  $3,055   $3,055 
Castings   209    209 
   $3,264   $3,264 
v3.23.3
Significant Accounting Policies (Details)
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies (Details) [Line Items]  
Customary payment terms, description Customary payment terms are 2% 30 days, net 40 days
Sales [Member] | Customer Concentration Risk [Member] | Firearms [Member]  
Significant Accounting Policies (Details) [Line Items]  
Percentage of sales 99.00%
Sales [Member] | Customer Concentration Risk [Member] | Unaffiliated Castings [Member]  
Significant Accounting Policies (Details) [Line Items]  
Percentage of sales 1.00%
Non-US [Member] | Export sales [Member] | Customer Concentration Risk [Member]  
Significant Accounting Policies (Details) [Line Items]  
Percentage of sales 7.00%
v3.23.3
Revenue Recognition and Contracts with Customers (Details) - Schedule of Revenue Recognized - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Schedule of Revenue Recognized [Abstract]        
Contract liabilities with customers at beginning of period $ 100 $ 1,031
Revenue deferred 1,468 1,680
Revenue recognized (132) (1,275)
Contract liabilities with customers at end of period $ 1,436 $ 1,436
v3.23.3
Inventories (Details) - Schedule of Inventories - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Inventory at FIFO    
Finished products $ 31,907 $ 23,573
Materials and work in process 118,114 105,721
Gross inventories 150,021 129,294
Less: LIFO reserve (64,969) (59,489)
Less: excess and obsolescence reserve (5,781) (4,812)
Net inventories $ 79,271 $ 64,993
v3.23.3
Leased Assets (Details)
Jul. 01, 2023
Leased Assets [Abstract]  
Lease term 8 years 1 month 6 days
v3.23.3
Leased Assets (Details) - Schedule of Right-of-Use Assets and Related Lease Liabilities - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Schedule of Right-of-Use Assets and Related Lease Liabilities [Abstract]    
Right-of-use assets $ 2,926  
Current portion 598  
Noncurrent portion 2,328 $ 3,039
Total operating lease liabilities $ 2,926  
v3.23.3
Leased Assets (Details) - Schedule of Operating Lease Liabilities
$ in Thousands
Sep. 30, 2023
USD ($)
Schedule of Operating Lease Liabilities [Abstract]  
Remainder of 2023 $ 200
2024 808
2025 702
2026 705
2027 229
Thereafter 1,120
Total undiscounted future minimum lease payments 3,764
Less: Difference between undiscounted lease payments & the present value of future lease payments (838)
Total operating lease liabilities $ 2,926
v3.23.3
Line of Credit (Details) - Line of Credit [Member] - USD ($)
$ in Millions
9 Months Ended
Jan. 07, 2022
Sep. 30, 2023
Line of Credit (Details) [Line Items]    
Unsecured line of credit $ 40  
Line of credit agreement, expiration date Jan. 07, 2025  
Line of credit charge percentage   0.25%
v3.23.3
Employee Benefit Plans (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Employee Benefit Plans [Abstract]        
Expenses related to matching employee contributions $ 1.0 $ 0.9 $ 3.7 $ 3.1
Future match of defined contribution plans     1.0  
Supplemental contributions total $ 1.6 $ 1.5 5.3 $ 5.4
Supplemental contributions to the plan during the remainder of fiscal year     $ 1.6  
v3.23.3
Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Income Taxes [Line Items]        
Effective income tax rate 8.10% 12.40% 18.90% 19.90%
Income tax payments $ 7.3 $ 6.0 $ 23.8 $ 26.6
v3.23.3
Earnings Per Share (Details) - Schedule of a Reconciliation of the Numerator and Denominator for the Basic and Diluted Earnings Per Share - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Numerator:        
Net income (in Dollars) $ 7,431 $ 18,389 $ 37,966 $ 69,378
Denominator:        
Weighted average number of common shares outstanding – Basic 17,722,682 17,668,435 17,705,280 17,643,473
Dilutive effect of options and restricted stock units outstanding under the Company’s employee compensation plans 166,407 157,362 123,430 126,647
Weighted average number of common shares outstanding – Diluted 17,889,089 17,825,797 17,828,710 17,770,120
v3.23.3
Compensation Plans (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Jun. 30, 2023
May 31, 2017
Compensation Plans (Details) [Line Items]            
Restricted stock units issued     113,862      
Total compensation costs     $ 6.1      
Total stock-based compensation $ 1.6 $ 1.7 $ 5.0 $ 5.1    
Stock Incentive Plan 2017 [Member]            
Compensation Plans (Details) [Line Items]            
Shares reserved for issuance           750,000
Shares remained unawarded 121,034   121,034      
Stock Incentive Plan 2023 [Member]            
Compensation Plans (Details) [Line Items]            
Issuance of shares         1,000,000  
Shares available for future grants 869,000   869,000      
v3.23.3
Operating Segment Information (Details)
9 Months Ended
Sep. 30, 2023
segments
Segment Reporting [Abstract]  
Reportable segments 2
v3.23.3
Operating Segment Information (Details) - Schedule of Operating Segment Financial Information - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
Dec. 31, 2022
Segment Reporting Information [Line Items]          
Net Sales $ 120,893 $ 139,390 $ 413,150 $ 446,618  
Income (Loss) Before Income Taxes          
Income (Loss) Before Income Taxes 8,089 20,991 46,814 86,614  
Depreciation          
Depreciation 6,229 6,389 18,688 19,166  
Capital Expenditures          
Capital Expenditures 6,764 2,876 11,637 17,206  
Identifiable Assets          
Identifiable Assets 400,350   400,350   $ 484,763
Goodwill 3,264   3,264   3,264
Unaffiliated Castings [Member]          
Income (Loss) Before Income Taxes          
Income (Loss) Before Income Taxes 420 (1,029) (1,178) (2,754)  
Castings [Member]          
Segment Reporting Information [Line Items]          
Net Sales 8,472 5,072 27,343 15,784  
Capital Expenditures          
Capital Expenditures 90 552 181 1,235  
Identifiable Assets          
Identifiable Assets 10,137   10,137   11,910
Goodwill 209   209   209
Firearms [Member]          
Income (Loss) Before Income Taxes          
Income (Loss) Before Income Taxes 6,108 21,339 43,637 88,130  
Capital Expenditures          
Capital Expenditures 6,674 2,324 11,456 15,971  
Identifiable Assets          
Identifiable Assets 230,340   230,340   223,301
Corporate [Member]          
Income (Loss) Before Income Taxes          
Income (Loss) Before Income Taxes 1,561 681 4,355 1,238  
Identifiable Assets          
Identifiable Assets 159,873   159,873   $ 249,552
Firearms [Member]          
Segment Reporting Information [Line Items]          
Net Sales 120,368 138,771 411,114 444,615  
Depreciation          
Depreciation 5,676 5,815 17,027 17,430  
Castings [Member] | Unaffiliated Castings [Member]          
Segment Reporting Information [Line Items]          
Net Sales 525 619 2,036 2,003  
Castings [Member] | Intersegment [Member]          
Segment Reporting Information [Line Items]          
Net Sales 7,947 4,453 25,307 13,781  
Eliminations [Member]          
Segment Reporting Information [Line Items]          
Net Sales (7,947) (4,453) (25,307) (13,781)  
Unaffiliated Castings [Member]          
Segment Reporting Information [Line Items]          
Net Sales 525 619 2,036 2,003  
Depreciation          
Depreciation $ 553 $ 574 $ 1,661 $ 1,736  
v3.23.3
Related Party Transactions (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Oct. 01, 2022
Sep. 30, 2023
Oct. 01, 2022
National Rifle Association [Member]        
Related Party Transactions (Details) [Line Items]        
Amount paid $ 0.1 $ 0.2 $ 0.4 $ 0.4
National Shooting Sports Foundation [Member]        
Related Party Transactions (Details) [Line Items]        
Amount paid $ 0.1 $ 0.1 $ 0.3 $ 0.2
v3.23.3
Contingent Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Jul. 10, 2000
Dec. 31, 2022
Dec. 31, 2021
Contingent Liabilities [Abstract]      
Minimum limit of per claim for providing insurance coverage on annual basis $ 5.0    
Maximum limit of aggregate loss incurred annually for providing insurance coverage on annual basis $ 10.0    
Total amount of damages claimed     $ 1.1
Total amount of damages claimed, description   de minimis  
v3.23.3
Subsequent Events (Details)
Oct. 27, 2023
$ / shares
Subsequent Event [Member]  
Subsequent Events (Details) [Line Items]  
Dividend authorized $ 0.17

Sturm Ruger (NYSE:RGR)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Sturm Ruger Charts.
Sturm Ruger (NYSE:RGR)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Sturm Ruger Charts.